Background: The welcoming and the taking care of the person at health level can be defi ned as indicators of quality of services and performances with reference to the individualization and humanization of the treatments. The "Carative Factors", the humanistic philosophy of caring, Human Caring, are factors that the nurse utilizes to lavish holistic cures, centralize the care, the taking care in an attempt to understand the interaction between health, disease and behavior. Objectives: To examine the hospitality capacity of the hematology nurse towards the patient that has to undergo Hematopoietic Stem Cell transplant to evaluate the assessment of the taking care of the same, not from the point of view of the quality of the technical treatment, but with regard to the humanitarian cares and enhance the person towards an increasing quality of life level through the satisfaction of more intimate needs. Materials and Methods: Area of investigation: Hematology Unit, HPC Transplant unit and Day-Hospital Unit/Oncohematology Surgery Policlinico Tor Vergata of Rome. Sample on which the study has been conducted consisted of 100 patients, 58 M 42 F, average age 44 years old, the mean time treatment was 20 months. Instrumentation used is the evaluation rating scale Health care Environment Caring Factor Survey (Jean Watson and John Nelson) currently in use in North America, the evaluation tool is the level of holistic satisfaction of the patients and of the cure that is provided to them by the structure. Questionnaire made up of 10 items, The interviewee answered by using the Likert scale (from 1=strongly disagree to 7=fi rmly agree). Conclusions: On the average the major part of the sample has responded positively with a deviation from the average. 50% of the sample does not reply or doesn't understand the item regarding the curative environment and the relation between mind, body and spirit with a knowledge defi cit regarding the potentiality of the nurse as given in charge of such cure. 90% expresses positively about their perception of caring factors such as helping relationship trust, loving kindness, attentiveness, problem solving, tolerance, respect and clearness in the communication.
Background: The welcoming and the taking care of the person at health level can be defi ned as indicators of quality of services and performances with reference to the individualization and humanization of the treatments. The "Carative Factors", the humanistic philosophy of caring, Human Caring, are factors that the nurse utilizes to lavish holistic cures, centralize the care, the taking care in an attempt to understand the interaction between health, disease and behavior. Objectives: To examine the hospitality capacity of the hematology nurse towards the patient that has to undergo Hematopoietic Stem Cell transplant to evaluate the assessment of the taking care of the same, not from the point of view of the quality of the technical treatment, but with regard to the humanitarian cares and enhance the person towards an increasing quality of life level through the satisfaction of more intimate needs. Materials and Methods: Area of investigation: Hematology Unit, HPC Transplant unit and Day-Hospital Unit/Oncohematology Surgery Policlinico Tor Vergata of Rome. Sample on which the study has been conducted consisted of 100 patients, 58 M 42 F, average age 44 years old, the mean time treatment was 20 months. Instrumentation used is the evaluation rating scale Health care Environment Caring Factor Survey (Jean Watson and John Nelson) currently in use in North America, the evaluation tool is the level of holistic satisfaction of the patients and of the cure that is provided to them by the structure. Questionnaire made up of 10 items, The interviewee answered by using the Likert scale (from 1=strongly disagree to 7=fi rmly agree). Conclusions: On the average the major part of the sample has responded positively with a deviation from the average. 50% of the sample does not reply or doesn't understand the item regarding the curative environment and the relation between mind, body and spirit with a knowledge defi cit regarding the potentiality of the nurse as given in charge of such cure. 90% expresses positively about their perception of caring factors such as helping relationship trust, loving kindness, attentiveness, problem solving, tolerance, respect and clearness in the communication.
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The route map of learning for health care support workers: developing a competency assessment for unregistered staff
H.L. Nisbett The Royal Marsden Hospital (Sutton, UK)
The RCN has acknowledged that in the last 5 years there has been an unprecedented increase in the number of health care support workers (HCSW's) working within the NHS (RCN 2007) .
As such the nature of nursing care delivery is changing and increasingly essential nursing care of vulnerable patients is being delivered by health care support workers in collaboration with registered nursing staff. It has also been recognised that there is a vast difference in expectations and job role clarifi cation for HCSW's across the NHS, leading to some disparity surrounding competencies and appropriate delegation of tasks. The CQC, DoH, NMC and the RCN have therefore called for some level of professional regulation for HCSW's to improve patient safety and to set general standards for education and competency that could be transferable between trusts. Within Haematopoietic Stem Cell Transplant (HSCT), FACT-JACIE (2011) require that in order to maintain accreditation, systems must be in place to document initial qualifi cations of all medical and nursing staff, and that provisions must be evident for continuing education and professional development (standard B4.3). FACT-JACIE also require that nurses be formally trained in the management of HSCT patients. Where management of treatment related toxicities and side effects cross over into the role of the HCSW's it should be implied that they too will require formal training in order to maintain high standards of care. This standard has been addressed at the Royal Marsden Hospital through several different avenues; trustwide by providing a HCSW development program with generic competency assessments, and locally within HSCT by developing a 'Route Map of Learning for HCSW's', adapted from a previous learning tool aimed at registered nursing staff working in HSCT. The 'Route Map' enables an initial and continuing assessment of knowledge and skills to occur through a series of HSCT related competency assessments, personal development plan and a variety of self directed study sheets surrounding standard operating procedures, policies and unit guidelines relating to the HCSW role. The self-directed element aims to empower HCSW's to gain specialist knowledge that will enable them to deliver safe, competent and timely care interventions in support of the registered staff. This poster will summarise the need for a HCSW specifi c learning tool and demonstrate the process of assessment/development required at this level within the HSCT unit.
At Oxford Bone marrow transplant unit, we believe it's vital that policies are in place and followed so that patients and their carers are given sound information to ensure an uncomplicated and safe transplant. Despite this we found ourselves in an unusal situation and our unit faced an ethical dilema. Patient A, a 19 year old female with MDS planned for full intensity MUD transplant with Campath, Cyclophosamide and Total body irradiation (TBI) conditioning. She received verbal information from Dr and BMT Co-ordinator regarding importance of using contraception to avoid pregnancy pre transplant. This was reiterated on several occasions. At Work-up 3 weeks pre transplant, had a negative pregnancy test.
At radiotherapy planning 2 weeks pre transplant had a negative preganacy test. Verbal responsibility taken by patient to use contraception but patient did not sign the disclaimer to confi rm this. On admission to ward pre conditioning a further negative pregnancy test result was obtained and conditioning regieme commenced with Campath and Cyclophosamide. 4 days later was due to commence TBI, however as radiotherapy department had no record of written disclaimer or previous negative test from planning day staff carried out a further test which was now positive. Impact on patient: Shock Faced with diffi cult decision Psychological and emotional impact Physical symptoms of pregnancy Risk of bleeding and infection. Advice we sought: Discussed with Obstectrics, unable to have a termination of pregnancy until 6 weeks pregnant but thought it highly likely she would naturally have a chemotherapy induced miscarriage. Discussed with BMT team re abandoning BMT until able to have medical termination, and re schedule allograft. Discussion with legal services stated that our responsibility was to the patient and we had a duty to provide optimum care for her to ensure the best outcome post transplant. Actions: Time spent supporting patient and discussing options, Made decision to continue with conditioning and TBI as planned but altered regieme from 8 fractions of TBI to 6 to keep to planned dates. Monitored her Beta HGC levels to monitor pregnancy and she spontaneously miscarried around 10 days later without any major bleeding or infection. Future recommendations: Be aware that policys aren't full proof. Review disclaimer policy, possibly puts too much responsibility on to patient and makes assumptions about their sexual behaviour and knowledge. Possibly to review sensitivity of tests currently used.
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Impact of fi rst-line plerixafor on the patient journey during stem cell mobilisation; the PHANTASTIC trial in Liverpool J. Bell, B. McEvoy, S. Watmough, E. Ion, S. Francis, T. Callaghan, R. Salim, R Clark Royal Liverpool Hospital (Liverpool, UK) Chemotherapy (usually cyclophosphamide) with GranulocyteColony Stimulating Factor (G-CSF) is the standard of care for mobilising stem cells prior to autologous transplant. Plerixafor is now available second line for patients failing chemotherapy + G-CSF mobilisation. We have gone a step further, with a trial of plerixafor (+ G-CSF) as fi rst line for stem cell mobilisation. The trial is known as PHANTASTIC. 61 myeloma and lymphoma patients have currently been entered. Here we report the way in which the PHANTASTIC trial has changed the patient journey during stem cell mobilisation and the challenges that the nursing team have faced. Previously, patients received chemotherapy+G-CSF. The chemo therapy was scheduled as a day case or, often, as an inpatient. This was not ideal, as the optimal harvest day(s) cannot be predicted in advance, complicating the planning of apheresis slots. This led to almost daily hospital visits and multiple aphereses. Also the stem cell yield may be poor, requiring further harvesting and delay in the eventual transplant. Plerixafor gives an optimal stem cell yield 10-16 hours after administration. We give plerixafor at 10pm on a Sunday, so the patient is always ready to harvest on a Monday morning. This may need repeating 24 hours later if insuffi cient cells are collected. Apheresis is therefore now easier to plan. As this S473 new method of harvest differed from previous chemotherapy + G-CSF, this required some initial adjustments by the ward nurses. Here, we defi ne a successful harvest as a round of harvesting that produces suffi cient stem cells to permit a subsequent transplant. With plerixafor, 93% of patients have been successfully harvested, in an average of 1.7 apheresis days. This appears fewer than previously, further decreasing the attendance days for most patients. We have seen the following side effects of plerixafor: diarrhoea, nausea, vomiting, headache, abdominal pain and insomnia. These are generally mild and resolve quickly on stopping; some may be due to apheresis rather than plerixafor. Previously with chemotherapy + G-CSF, we saw occasional admissions with neutropenic sepsis; we have seen none after plerixafor. In summary, in the last 17 months, PHANTASTIC has changed the way we conduct harvests. The vast majority of patients have a successful harvest, with fewer side effects. It is possible that this could improve overall survival.
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The impact of accessing treatment away from the transplant centre on the patient and support services J. Cooper, G. Spratt, K. Wilson Nursing (Newcastle, UK) The Haemopoietic Stem Cell Transplant (HSCT) Unit at the Great North Children's Hospital, Newcastle-Upon-Tyne, cares for patients with immune disregulation or dysfunction from the Northern UK. Patients are also increasingly referred to the service from worldwide destinations. Many HSCT's are successful and without complications, however, Graft Versus Host Disease (GVHD) is always a risk. An overseas adolescent patient underwent HSCT for chronic granulomatous disease and later developed GVHD of the skin, upper and lower gut (Grade IV). After unsuccessful conventional treatment, it was decided he would benefi t from a course of extracorporeal photopheresis (ECP). ECP involves removing the circulating leukocytes and platelets which are treated with Uvadex, exposed to Ultra Violet (UV) light and returned to the patient. Treatment is initially two cycles given in alternate weekly sessions, usually as an outpatient. Currently, Newcastle-Upon-Tyne does not provide this treatment for children and therefore the patient had to be transferred 107 miles to another hospital to undergo this therapy. As the patient was very unwell and requiring high dependency care for critical fl uid management and a complex medication regime, it was necessary for him to be accompanied and cared for by two specialist nurses for the duration of his journey and treatments. The patient became extremely anxious in the days leading up to the transfer for each treatment. Staff recognised his concern about the journey and his stay in an unfamiliar environment. His anxieties caused his physical condition to deteriorate, subsequently he became emotionally withdrawn. On return from each treatment he took several days to recover physically and psychologically. This presentation will discuss the emotional, physical and fi nancial implications encountered by the patient, family and staff in the delivery of this treatment and the steps taken and lessons learned by this course of events. In conclusion, the patient achieved a positive outcome to his treatment despite the stress and anxiety caused by the experience. Although ECP was successful to date, the authors consider that progress may have been achieved sooner, individual staff would have remained unaffected and there would be less pressure on the services if this treatment had been available in Newcastle.
P1257 Do we believe in magic? S. Vieira, D. Monroe The Trustee of London Clinic (London, UK)
Introduction: Plerixafor (MOZOBIL®) is an antagonist of alphachemokine receptor CXCR and one of the new additions to the Haematology discipline; it is used as a stem cell mobiliser. It is indicated in combination with Granulocyte Colony Stimulating Factor (GCSF) for Peripheral Blood Stem Cell (PBSC) collections in the Multiple Myeloma (MM) and Lymphoma patient group with a poor mobilisation history. Method: In our organisation, data was collected prospectively. 19 patients (one patient was included twice as she/he received prelixafor on two separate occasions) received Plerixafor for PBSC collection between May 2009 and September 2010. Patients met the criteria prior to treatment, except three patients with low platelet counts. Result: 11 of the patients were diagnosed with MM and three with Non-Hodgkin's Lymphoma (NHL), three patients had Hodgkin's Disease, one had Neuroblastoma and one with Walderstorm's Macroglobulinameia. All patients received four consecutive days of GCSF 10 μg/kg prior to Plerixafor. Plerixafor was given 10 hours before the PBSC collection and GCSF was repeated one hour prior to PBSC collection in the morning. All patients received 0.24 mg/kg/day of Plerixafor. There were no side effects observed in these episodes. Three patients required a second dose of Plerixafor and one patient with Walderstorm's Macroglobunimeia received a third dose. For all cases, the target CD34+ count was 4 x 106 cells/kg of recipient body weight. Two patients responded extremely well with a CD34+ count of 21.79 x 10 6 cells/kg and 15.16 x 10 6 cells/kg achieved and the remaining seven patients had achieved the target of 4 × 10 6 cells/kg or above. However 11 patients failed to achieve to reach target. Six of these patients had adequate amounts of CD34 count for an autologus transplant. Four patient failed to mobilise with CD 34+ < 2 × 10 9 cells/kg. Only one patient had no CD34+ at all. Conclusion: Plerixafor was used at The London Clinic recently with mostly favourable outcomes. According to this study Plerixafor has improved PBSC outcomes with one exception. Plerixafor has defi nitely made a positive difference in 45% of our patients and 30% had enough cells for an autologus transplant. More than one dose of Plerixafor may be required for heavily pre-treated patients who are historically poor mobiliser of PBSC collections.
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Is it the start of a new era? S. Vieira, M. Madziwanzira, D. Monroe The Trustee of London Clinic (London, UK) Introduction: Neulasta™ (Pegfi lgrastim) is a covalent conjugate of recombinant methionyl human Filgrastim (GCSF) and monomethoxypolyethylene glycol. Primarily, the indication of Neulasta™ is to decrease the incidence of infection as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs, associated with a clinically signifi cant incidence of febrile neutropenia. The major cause of treatment related morbidity and mortality in patients with acute leukaemias is due to infection with and due to prolonged neutropenia. Neulasta (Pegfi lgrastim) is known to be as effi cacious as Filgrastim in reducing chemotherapyinduced neutropenia and is licensed for use in autologus stem cell transplantation. In our centre Neulasta is also used post chemotherapy in order to shorten neutropenia and reduce febrile episodes & potentially hospitalisation. Our aim was to explore whether Neulasta could be useful in other chemotherapy treatments. Methodology: Our study was carried out retrospectively. It included 34 patients with haematological malignancies, only in-patient episodes were included. Patients' data is presented in Table I . Even though R-CHOP is given as an out-patient treatment; there are two patients who received R-CHOP included in this study due to their tendency to become neutropenic after each cycle. Therefore it was considered these two patients should be included. Results: The majority of patients who are included in this study suffer from acute leukaemia and Non Hodgkin Lymphoma (See Table I ). Chemotherapy regimens given are also listed in Table I . Most of our patients had a quick neutrophil recovery time (mean value: 4.8 days). There are large numbers of studies published regarding the duration of neutropenia induced by chemo therapy, these studies states neutropenia can last between 2-3 weeks. In our study, 76.5 % (26) of patient had neutrophil recovery by 10 days or less, 44.2% of our patients had no febrile episodes and 29.4% of patients were managed as out-patient. Only 11.6% of patients required additional GCSF. Conclusion: In our unit we believe Neulasta has achieved favourable outcomes in our patients by shortening the period of neutropenia and reducing febrile episodes and therefore hospitalisation.
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Allogeneic bone marrow transplants -only for young patients? N. Atar, S. Torati, I. Sabah, N. Hatib, L. Marudi General Hospital (Ramat Gan, IL) An Allogeneic Myeloablative Bone Marrow Transplant (ABMT) is the best curative treatment known today for patients who suffer from hematological illnesses such as AML & MDS. Up to 10 years ago, an ABMT was as option offered only to patients younger then 40 years, although most patients diagnosed with such diseases are older than 60. This group of patients has poor prognostic factors and a high risk of relapse if not transplanted. The age preferences was due to the high risk of morbidity and mortality from the treatment. Since then, reduced intensity conditioning was introduced. This treatment allowed older patients to go through an ABMT. Recent studies showed an increase in overall survival and better prognosis in this age group. Furthermore, this therapy did not show an increase in the non-relapse mortality (NRM) rate. This approach changed the treatment concept, and accordingly the inclusion criteria for ABMT. It forced the nursing staff, to fi t the nursing for this population. Purposes: To check the nursing staff's knowledge regarding ABMT in older patients and according to the results of the
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S475 questioners, try to fi t a suitable training program and proper resources in the department. Methods: The nursing staff's position towards treating older patients was checked with questioners. The staff was also asked to suggest how they could improve the quality of care and infl uence the patient's quality of life after the transplant. 30 staff members fi lled out the questioners. Results: The nursing staff was found to have little knowledge regarding treating older patients during and after an ABMT. They believed that further training, suitable resources, appointing case management nurses, proper rehabilitation, close follow-up and supervision will assist to reduce NRM of older patients. Conclusions: Even though background illnesses and performance status are key factors in the decision whether to perform an ABMT, age isn't a contra-indication. Improving the treatment, building suitable treatment plans, refreshing the knowledge and training of the staff and appointing a case management nurse, can signifi cantly reduce the NRM due to ABMTs. Following these conclusions, a unique training program was initiated at the BMT department, Sheba Medical Center. Each patient receives a case management nurse who accompanies, guides and supervises from the fi rst day of hospitalization, through the transplant up to discharge and continues through dare care follow-up.
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The transplant of haematopoietic progenitor cell with the PICC catheter: the experience of the operating unit of the transplant haematology in a polyclinic, Tor Vergata (< 20000 PLT/Ul), 93% had more than 40000 PLT/Ul. The vein chosen for the PICC positioning has been the basilica in 93,5% of the cases. The mean life of catheters has been of 121 days, with a maximum of 377 days and a minimum of 20 days. 20 PICC are currently in use without any kind of complication. The average incidence of removal for bacteriemia associated to the PICC has been of 0.75 per 1000 days/catheter. The average incidence of removal for thrombosis has been of 0.5 per 1000 days/catheter. The average incidence of removal for malfunction (migration) has been of 0.25 1000 days/catheter. The average incidence of death removal has been of 1.51 per 1000 days/catheter. Comments: Such data, in our opinion, encourage the use of PICC in the hematological Pz who has to undergo a HPC transplant. The limited impact of thrombocytopenia on the complications of positioning and on CVC-correlated infections makes PICC an instrument of great utility also in the delicate early stages of the HPC transplant, making it comparable to tunneled catheters or at short stay. In addition, it is emphasized a reduction of the complications correlated to the insertion and a simpler removal in case of bacteremia. Background: Chronic lymphatic leukemia (further CLL) ranks among the most frequent kinds of leukemia in adults in Europe. This is an indolent lymphoproliferative disease. This disease is often diagnosed by accident; however, some forms with a more aggressive course are diagnosed on the basis of expressive clinical signs, e.g. B symptoms. The nursing staff look for, remove, relieve and prevent the patients ' problems in the area of human needs. The nursing diagnoses describing the patients` nursing problems can be topical, potential or educative and they always refl ect the patient ' s biological, psychological, social and spiritual condition. Methods: The retrospective analysis of patients ' health care records was chosen for the data collection. The patients treated for CLL at the Internal Hemato-Oncology Department of the University Hospital, Brno, between 2004 and 2008 were included in the survey. The total number of patients was 230. The data were processed by classifi cation methods of the degree I and II. Results: The sample studied consisted of 63% men and 37% women, the average age being 65 years. In 64% of the cases, the suspicion for CLL was based on examinations of other causes, only in 36% it was based on clinical symptoms. The positive occurrence of symptoms in the time before the fi rst examination was identifi ed in 47% patients. The most frequent symptoms were represented by weakness and fatigue 39%, B symptoms 34%, enlarged nodes 34%, and infectious complications in 29% patients. The fi rst contact professionals were represented by general practitioners in 50%, by internal doctors in 27%, by other professionals in 21% (e.g. urologists) and by surgeons in 3%. 32% patients were referred directly by the general practitioner to the examination at a specialized centre, while 68% patients visited other 1 to 3 specialists. The mean time between the fi rst visit to the doctor and the determination of the fi nal diagnosis was 22 days. Conclusions: The CLL patients do not only experience physical suffering, but they can have psychological and social problems as well. The care of these patients demands versatile cooperation. As shown by our survey, these patients can be met not only in specialized cancer centres, where trained staff take care of cancer patients, but also in outpatient clinics of general practitioners and nurses or other professionals. Their role in early detection of CLL is important.
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The future direction of ambulatory care at a university college hospital, London N. Bates, L. Mcmonagle University College London Hospital (London, UK) The Ambulatory Care Unit (ACU) at University College London Hospital (UCLH) was established in January 2005 to provide treatment for varying malignancies requiring chemotherapy and bone marrow transplants (see graph A). Patients attend to receive their treatments daily and if well, are discharged back to the hotel or home. If they require admission overnight there is a blocked bed on the ward. Current capacity is 12 and it is staffed by three nurses and one administrator. Since opening we have conducted over 400 transplants (see graph B). ACU is a popular endeavour to UCLH. Regular audits show high levels of patient satisfaction, whilst also being cost effective compared to inpatient treatment. Treating transplant patients in ACU has been made possible by the use of Computerised Ambulatory Drug Delivery (CADD). This allows us to deliver what was historically an inpatient chemotherapy regime in an outpatient setting.
Future Direction of ACU In recent years ACU has expanded, in terms of capacity and treatment regimes and we have outgrown our current location. In April 2012 the £100 million UCLH Cancer Centre will open. For ACU, it will mean an increase in capacity to 18 including more transplant activity, as there will more access to side rooms. The success of ACU and the planned expansion of the service have led to the development of the 'hospital hotel'. This will provide patients with access to everyday amenities (e.g. kitchen, laundry) and gives us better control over our patient environment. Having proven to be safe and effective, it is encouraged that all suitable patients commence their treatment in ACU. We still fi nd patient perceptions diffi cult to overcome but hope as the
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S477 service increases in reputation, they will become more familiar with the concept. By bringing more patients through ACU, we will ease the pressure on inpatient beds. To facilitate this process, we are developing a partnership with 'Healthcare at Home'. Currently this service is provided to our harvest patients requiring Plerixafor, with plans being made to extend this to delivering chemotherapy regimes in the home. Conclusion: ACU attracts attention to UCLH because of the positive impact it has on patients, on the transplant service and the hospital in general. We will continue to strategise to provide more treatments in this atmosphere, thereby giving patients more choice as to how they are treated.
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Outpatient-Allo! Feasibility of reduced-intensity stem cell transplantation in an outpatient setting A.M.G. Kramers-de Boer, A. Nijntjes, O. Visser VU University Medical Center (Amsterdam, NL) Objectives: Standard conditioning therapy for myeloid disorders is fl udarabine [intravenously] and total body irradiation (TBI) followed by allogeneic stemcell transplantation. Until now, fl udarabine is given intravenously and therefore patients have to be admitted for at least 5 days. It is known that fl udarabine can be given orally which is well tolerated. So with the introduction of fl udarabine orally in combination with TBI (2 Gray), we expect that it is not necessary to admit patients for this conditioning therapy.Therefore we want to assess the feasibility of this procedure in an outpatient setting, before implementing this as a standard of care. Methods: In January 2012 we will initiate a pilot study with a group of patients (n=8) with a myeloid disorder who are planned to undergo an allogenic reduced intensity stemcell transplanstation (RIST) with fl udarabine orally and TBI conditioning. Patients will visit us 7 days prior to transplantation to validate the procedure: performing fi nal medical examinations, check the given information and prescriptions. Five days prior to transplantation, they will start with the conditioning at home. TBI will be done at the morning of transplantation. Regular follow up visits as well as check by telephone will be planned. Results: Every procedure in this pilot study will be evaluated for safety and feasibility. The evaluation will take place on the concept of the Plan-Do-Check-Act cycle, so adjustments in protocols en interventions can be made directly. Patients and their caregivers will be regularly interviewed on satisfaction and well being. Conclusion: The aim of this presentation is to discuss our fi rst experiences with allogenic RIST in an outpatient setting from different perspectives (patient, caregiver, members of the transplantation team, etc.)
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How good are yours? An audit comparing bone marrow specimen quality among practitioners within a regional haematology service M. Kelly, K. Perera, G. Crotty, R. Morrell Midland Regional Hospital (Mullingar, IE) Introduction: This abstract presents an audit of BM specimen quality among practitioners within a regional Haematology service and compares the fi ndings with recent guidelines. Purpose:
-Assess the quality of BM aspirate and trephine performed within the service. -Compare practitioners abilities.
-Compare fi ndings with published research and guidelines.
Method: A specially designed audit card was completed when the BM was examined. Details captured included patient id, indication for BM, aspirate quality, marrow spaces trephine length and comment. The audit was completed between August 2010 and July 2011. Findings: 118 audit cards were completed. 61% of BM were completed by the ANP, 5% and 33.8% were performed by the consultant haematologist and registrars respectively.
-Overall the BM aspirate quality was very good (11%) or good (63.5%). -18.6% were Haemodilute. Haemodilution was attributable to the underlying BM pathology in 8 cases. -5% were poor and 1.6% Hypocellular. -BM aspirate spread was found to be very good 11.9% and 47.4% were good. 13.5% of specimen were haemodilute. -Spread could be better in 23.7%. BM Trephine length evaluation was completed following fi xing. The audit revealed 23.9%/34.1% of BM trephines were less than the recommended 1.6 cm 3 / 2 cm optimum length. 3 samples contained cartilage and 2 clots. Further evaluation of BM trephine specimens revealed 87.2% had suffi cient marrow spaces of > 6 suitable for analysis.1 BM did not yield a trephine sample. 97.4% had a confi mred diagnosis on BMs. Discussion: Limited published literature on BM specimen quality and practitioner competency exists. This audit revealed the ANP and medical practitioners were equally competent.In our audit the majority of BM specimens were of very good or good quality. BM performed by the medical group had a higher incidence of reduced quality aspirate and spread. Although trephine length is important it does not always refl ect the quality of the biopsy or number of marrow spaces available for examination. Our audit 5 specimen contained cartilage and clot. Our audit also examined the number of BM spaces and revealed adequate marrow spaces for the majority of specimens. Conclusion: We can conclude the majority of BM specimens were of very good or good quality. We are meeting international standards for BM specimen.Finally BMs obtained by the ANP compare favourably with those performed by haematology medical colleagues.
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Ambulatory low-volume bone marrow harvesting together with BMT nurses R. Radiano, D. Gozal, B. Bogorochin, R. Or Hadassah Medical Organization (Jerusalem, IL) Introduction: Patients and donors requiring low-volume bone marrow (BM) harvesting often undergo general, epidural or spinal anesthesia in the operating room under the care and nursing of their team. The aims of this study were to investigate the feasibility of low-volume BM harvesting under deep sedation only being performed in the BMT day care unit by the department's physicians and nursing team. Our ambulatory care team studied the results of this procedure and described its psychological, medical, and technical advantages. Methods and Interventions: The protocol, which involves bi-lateral posterior iliac crest infi ltration with IV sedation is less invasive than general, epidural or spinal anesthesia and therefore is met with greater cooperation on the part of donors. Donors lay face down, vital signs were monitored continuously, and IV Propofol and Alfentanil were administered, followed by local anesthesia. If a patient reported pain during the procedure, additional bolus of IV Propofol and Alfentanil was administered, providing relief within 30 sec. The mean volume of bone marrow product for adult patients was 250 ml. Procedure duration was 30±10 min. Patients were alert within 8±2 min after the procedure and were discharged the same day. Results: Data were obtained retrospectively from 10.2007 until 12.2010 on 198 consecutive cases. Patients included candidates for allogeneic SCT that needed autologous back-up marrow, healthy donors for the preparation of bone marrow-derived mesenchymal stem cells and patients suffering from neuro-degenerative diseases for cell therapy. Female/male distribution was S478 43.2%/56.8%, mean age 47 yrs. Analysis of our data confi rms that our sedation protocol is safe and simple for bone marrow harvesting. No cases required conversion to general or epidural anesthesia. Nurses reported that patients were less anxious, and that staff felt better able to modulate the patient's level of alertness. Only one patient developed severe and prolonged upper airway obstruction with apnea, and required short assisted manual ventilation with insertion of nasal airway and was resolved completely. Conclusions: By following routine, defi ned parameters within the sedation protocol, BMT nurses providing comprehensive care in the ambulatory setting of the BMT day care unit, found this protocol useful. It provides reliable, profound, analgesia without the necessity of invasive anesthesia. Furthermore, it spares signifi cant time load in the operating theater system of the hospital. Our study represents the safest way of managing a patient undergoing low-volume BM harvesting and establishes a unique collaboration between transplant surgeons, anesthetists and BMT nurses. Results: The length of stay for hospital inpatients ranged from 18-164 days, with the median being 50 days. 7 out of 12 patients died on critical care, only one of these were on the Liverpool Care Pathway. 3 patients died on the transplant unit on the Liverpool Care Pathway. 2 patients had support from their GP, district nurse, and Macmillan at home and died at home. 1 patient was in an intermediate care facility. These 3 patients are not included in the length of stay. Non transplant related mortality (Non TRM) consisted of 4 patients had relapsed disease, 1 patient had H1N1 virus. Those who had transplant related mortality (TRM), 2 patients had acute graft versus host disease, 4 had respiratory failure secondary to infection, and one patient had graft failure. 5/12 were know to hospital palliative care team. 3 of these were the patients with relapsed disease. Conclusion: From the information reviewed palliative care involvement was limited. Questions could be asked such as are we involving palliative care early enough especially as the length of stay for these patients is lengthy? However the results don't look at the transition from curative to palliative. It does highlight the complexities of transplant patients. There is a need for further research into palliative care and transplantation, with the possible better use of end of life care tools.
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Management of central venous catheter at home: a DVD for parents S. Calza, A. Granata, E. Ghibaudo, M.G. Deiana Giannina Gaslini Children's Hospital (Genoa, IT) Introduction: In recent years, the centrality of the patient and his family has been widely recognized. Education is essential to achieve therapeutic levels of safety and autonomy necessary for the management of the disease, both during hospitalization than at home. Patient and family's education are the expressions of a change in the ways of understanding the health of the patient. For this reason Training the parents to manage at home the CVC, whose use is very important and not only for cancer patients, is crucial. In the case of patients with CVC, proper education to the child and family permits, compared to the fi rst point of Each card, that the child must be hospitalized only if the assistance needed cannot be provided at home, equally well, or in outpatient treatment. Purpose: To create an interactive multimedia tool for parents education in the home management of CVC. Materials and Method: Search on the main online database the evidence regarding the topic and the CVC line; Questionnaire administration to parents of patients with central venous catheter who agreed to learn to manage it at home; Data collection and analysis; Design interactive DVD; Dissemination of DVD. Results: The importance of therapeutic education, respect for the child's rights, the results of the questionnaire and review of the literature have reinforced the planned construction of an interactive DVD for the home management of CVC, which constitutes an effective mean in the education of the child and his/her family. Conclusions: It is' evident that the role of the nurse should also be the facilitator of education, and it can be done best with the use of multimedia methods as literature suggests. Next step will be to evaluate if the education given is effective and if parents are satisfi ed with this tecnique. Introduction: Over the last decade, information for cancer patients has become increasingly more available. The very nature of cancer requires patients to learn about their disease in order to cope with the consequences of treatment and to be involved in decision making processes. It is therefore vital to provide enough information for patients and their relevant others. This study aims to explore how much information our patient group wants to know and how much information our team provides. Method: A questionnaire was prepared to collect data on how much information was given to patients on three different stages of their treatment plans. These stages were: on admission, during their inpatient stay and on discharge. A fourth section was added, to investigate other information that patient felt would be benefi cial. 85 questionnaire were given between May 2010 and October 2011, outcome data is shown in Table I . Result: 85 malignant haematology patients were admitted to our unit for various reasons (See Table II ). Our audit was evaluated in three different stages. The admission stage; most of the information provided regarded side effects of treatment, test results (See Table I ). Our audit has shown that, admission stage was the lowest in terms of information providing. It should be kept in mind that the haematology patient group generally has a long hospitalisation; the data collection tool was given on discharge. Therefore, it was interpreted that data might be lost due to poor recall of the information required. Result showed that Sexuality (8.2%) and fertility (10.5) were the least addressed topics; where as results of diagnostic test (52.9%) was deemed the most important. On the other hand results also showed our patient were happy about the information they were given especially on discharge, as most aspect of information was covered (See Table I ). Conclusion: For the haematology patient group, knowing their diseases and potential outcomes does help in the diffi cult decision making process of their treatment. Therefore as healthcare professionals it is our duty of care to provide the information they need, but how far do we need to go? This study was aimed at exploring our patient groups information needs as well as self performance check. Our audit showed that our centre does perform well in admission and discharge stages; we need to work on the in patient period. It is considered to give data collection tool on admission rather than discharge.
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The role of the bone marrow transplant nurse and the Oxford allogeneic stem cell transplant patient pathway
D. Wareham, M. Ellis, L. Rowley Oxford University Hospitals NHS Trust (Oxford, UK)
Allogeneic stem cell transplantation is a complex and intensive treatment modality that requires extensive planning and preparation. In Oxford, we believe that a positive patient experience relies on a well co-ordinated and collaborative approach to the process. It is crucial that the patient, their family, and the transplant team have a clearly defi ned pathway that offers an element of simplicity, amidst the complexity of the procedure. All patients referred to the Oxford Blood and Marrow Transplant (BMT) Programme for an allogeneic stem cell transplant will have access to a BMT Nurse Co-ordinator and a BMT Clinical Nurse Specialist. The BMT Nurse Co-ordinator plays a pivotal role in the coordination and management of patient and donor activity pretransplant. With careful organisation and planning she will provide the patient with an individual transplant schedule and through assessment, education and support she will ensure that the patient is prepared for the journey ahead. She will offer ongoing support and education to the patient, their family and other members of the multidisciplinary team (MDT) at all stages of the transplant process. The BMT Nurse Co-ordinator will also co-ordinate and manage the care of sibling donors or liaise with the donor registry when the patient is to receive cells from an unrelated donor. The Bone Marrow Transplant Clinical Nurse Specialist plays a key role during the in-patient phase of the patient's BMT journey. During this time she will oversee the care and offer increased levels of support, advice and guidance to the patient, their family and other members of the MDT. When the patient is ready to go home she will help to coordinate the discharge, ensuring that the patient and their family and where appropriate, district and community health care professionals, feel prepared for the next phase of their transplant journey. This poster illustrates the BMT nurse involvement in the Oxford allogeneic stem cell transplant patient pathway.
P1270 Knowledge is power E. Ginati Sheba Medical Center (Ramat Gan, IL)
"Hospital Without Pain" is one of "Safra" children's hospital's main goals of the last decade. In our Pediatric Hemato Oncology department a special anesthesia room was designated to perform many procedures under general anesthesia regarding the disease and treatment for our children. To sustain this goal the nursing staff initiated a quality of care program containing guidelines, protocols and a pantomime motion picture with emphasis on reduction of anxiety levels in children and their parents. The purpose of this research was to reduce the level of anxiety and thereby develop an appropriate teaching protocol. Method: Examine the anxiety levels of children age 14 and above, before and after their fi rst general anesthesia experience. Examine the anxiety levels of parents before and after their children's fi rst anesthesia experience. Tools: Spielberg questioners (1973; 1970) on anxiety levels were preformed for children 14 to 18 years old before and after fi rst anesthesia, as well as for their parents. 19 children and 23 parents answered before and after questionnaires, followed by minimal oral preoperative instructions by the nurses. Results: Parents -decrease of 45% in general anxiety levels and decrease of 55% in situational anxieties.
Children -decrease of 61% in situational anxiety levels. At the conclusion of the questionnaire participants were also asked how they preferred to receive the information: Parents -23.3% written (Pamphlets) 41.9% visual (fi lm or Power Point computer presentation) Children -33% visual 20% written * 20% of questioner was invalid due to inadequate compliance. Conclusions: Anxiety levels of parents and children›s decreased when preoperative anesthesia education including written materials was provided by nurses. Today this project, providing general anesthesia in our department, has become a routine protocol prior to anesthetizing children. Our research results validate the the need for appropriate pre anesthesia information. Our Pamphlets, along with a short clown pantomime fi lm for children who do not yet read and our non Hebrew speaking multi national population, fulfi ll this need.
P1271 Tools to use when communicating with multicultural children and their parents A. Rajatammi, S. Nieminen Helsinki University Hospital (Helsinki, FI)
Cancer and haematology ward is located in the Hospital for Children and Adolescents in Helsinki. The Joint Accreditation Committee-ISCT Europe (JACIE) accredited ward gives treatment for one third of all the children and adolescents who have cancer in Finland. Growing immigration has started to show also in our ward too. During the recent years we have started to get more patients to our ward who either do not talk fi nnish, know only few words of fi nnish or do not have any mutual languages with the nurses. The use of interpreter, expressive behaviour, communicating through the parents, dictionaries, online translators, scales, and picture cards are given examples of different tools what to use when communicating with a child or a parent who does not talk the same language. The examples are based on real life cases of using these tools in our ward. The use of computers has made it possible to use computers as an aid when trying to explain something. The internet is full of different language translators and dictionaries that are replacing the old fashioned dictionaries. Using an interpreter is probably the most ordinary way to communicate with a child, parent or both of them. Not only are the offi cial interpreters used but also it is common to use a family member to translate. Older children are able to learn fi nnish with the aid of school teachers who come to visit the older children on regular basis. The smaller children can be introduced to fi nnish language with the games. Scales, pictures and picture cards are helpful when trying to help the child to visualise and understand when there is a language barrier and when neither parents nor interpreters are available. A Visual Analogue Scale (VAS) is a measurement instrument that is very helpful tool. The child might be able to express that the knee is hurting but verbally is not able to rate the pain. With the use of scale the child can easily show the rate of the pain even though there is no mutual language. The tool what to use when communicating with children and their parents are depending on themselves. It varies with every patient case and all the tools that might have worked with one child do not necessarily work with other. Multiculturalism and dealing with patients from different ethnicity is not so well discussed in our ward and it will certainly be a current topic in near future if immigration to Finland keeps growing.
P1272 Patients' experience point of view in protective isolation and health care workers' feelings in an allogenic haematopoietic stem cell transplantation unit A. Paccot, D. L'Héritier Hopitaux Universitaire de Genève (Geneve, CH)
At Geneva University Hospital (HUG), hospitalized patients for allogenic haematopoietic stem cells transplantation are placed in protective isolation. This isolation point out to protect immunosuppressed patients from colonization or germs infection requires the implementation of strict hygiene measures. The patient experience in protective isolation and caregivers in such unit has been unstudied. Goal: Firstly, the study objective is to know patient experience and, secondly to understand the experience of health care workers (HCW) in the same department. Method: Two semi-structured interviews have been made with patients in protective isolation admitted to the hematopoietic stem cells transplantation unit aged over 16 years old. Then, a focus group of three nurses and four nursing assistants working in HUG in the internal medicine department have been conducted. The recorded data have been anonymized, transcribed word by word and fi nally encoded. The data has been analyzed by the method of grounded theory in relation to a framework of nursing key concepts such as Mc Gill's model, empowerment, coping and health education. Results: The liberty's privation, confi nement, social isolation, loneliness, boredom, and lack of physical contact are the most often feelings cited, particularly in post transplant period. However, the disease, the transplantation success and the future perspective prevail over being in isolation. Patient's preferred coping strategies are fi rstly looking for social support (especially by support from close familiy and their accompaniement) and secondly "distraction" strategies (using TV, Internet, phone, and photos). The HCW experience comme out in directly as they express themselves through the patients feelings. Also, they agree on the importance of personalized information and health education in consideration of the factors such as age, disease grade acceptance, culture, life history and sociocultural level. Conclusion: To consider patients experience in protective isolation and also give information, is the nurse's major role and it's necessary to empower the patient and ensure safe care.
P1273
Parents' participation and teamwork between nursing staff is essential for positive outcome, when caring for a critically ill infant undergoing SCT on HFO and ECMO I. Hvidt, S. Christensen Rigshospitalet (Copenhagen, DK) A 4 month old boy was admitted to the childrens ward with symptoms of vomiting, diarrhoea and shortness of breath. Within days his respiratory symptoms worsened and he was transferred to PICU (pediatric intensive care unit), where mecanical ventilation was started. He was diagnosed XL-SCID and preparations for a SCT began. Since the infants condition was not improving it was decided to perform a haplotransplantation using the father as donor. The father was a one locus 9/10 allelie match. The infant was not conditioned and received cyclosporin from day -1 and MTX on day +1, +3, +6 and +11 as GvH profylaxis. Due to Pneumocystis jerovicii pneumonia the infant needed further respiratory support and was put on HFO (High frequency Oscilation) and ECMO (Extra corporal membrane Oxygenation). To ensure the position of the ECMO catheters and the ET tube he was kept sedated and on continuous painmedication. He was on ECMO for 18 days. On day +36 he was transferred to childrens ward in CPAP (continuous positive airway pressure) awake, but lethargic. On day +60 the infant was discharged from hospital, smiling to familymembers and looking like a healthy, little boy.
Nursing challenges:
1. Change a PICU room into a SCT room with laminar hepafi ltration. 2. Keep isolationprecautions in a room with a lot of tecnical equipment and 3 or more persons present at all times. 3. Preparing a SCT handbook for PICU nurses with little experience in caring for children undergoing SCT. 4. Nurse specialist (SCT) working as a consultant for PICU nurses.
Using principels from Familycentret Nursing and Paulo
Freire`s empowerment theories to teach parents to participate in caring for their cricically ill infant. 6. Preparing parents for the change from a critical care setting with 2-3 nurses present at all times in the room to childrens ward with less staff and less monitoring of the infant. 7. "Reading" the infant correctly in order to keep weaning him off pain-and sedative medication.
P1274 Information for haematological patients M.c.w. Goedhart, M. Bouwens Erasmus MC (Rotterdam, NL)
Introduction: On the departments of oncology and haematology in the Erasmus MC, all patients receive a nursing consultation before they start their fi rst treatment. In the consultation patients are instructed how to administer medication, the expected effects of the medication, possible side effects and the procedures surrounding day care at the hospital. All information that is provided orally is also sent in writing to the patient's home. Following research into the education and aftercare for patients with haematological treatment it was shown that: the information is most effective if several methods of providing the information are used, thus stimulating multiple senses. In addition, the greater the involvement of the patient, the more impact the information has.
The following principle was used to ascertain how much information a person remembers from the information they receive: From the results of this research we came to the conclusion that we should be able to increase the effectiveness of the nursing consultation by using different methods. We used the rules of thumb for providing information according to Vessies, Wiering, Elsinga & Van de Wiel (2008) , as guidance. These are:
-do not give too much information, especially when it evokes emotional responses -divide and repeat the information -use the level of language in line with that of the patient's -use drawings during the explanation -give the patient brochures and afterwards provide information in a letter -let the patient repeat what has been told in their own words -adapt the information to the wishes of the patient.
Future: Following the study, we developed a pathway that we are going to integrate into the nursing consultation. Improvement:
-use multiple methods of providing information -adapt the information to the needs of the patient -develop an information DVD and a photo book -be consistent with the information provided by the doctors Conclusion: The current situation shows that we make insuffi cient use of the various methods available to provide good S482 information to patients receiving chemotherapy, thereby the patients to not retain adequate information. By implementing the above improvements we should be able to enhance the quality of information.
P1275
The incidence of pulmonary and bronchial infections in patients after haematopoietic stem cell transplantation performed in HEPA or non-HEPA fi ltered rooms -observational study -interim results E. Bystricka, R. Brandejsova, J. Skardova, S. Vokurka, V. Koza, I. Skoda-Gorican, J. Pretnar, E. Mazur, A. Kopinska, M. Labudikova, J. Vitkova, K. Indrak, R. Ghelase, D. Colita, V. Pavlicova, J. Bockova, E. Tothova, J. Malý, D. Hrabankova-Navratilova, B. Šilerova, M 
. Trneny on behalf of the East Forum Nurses Group
Introduction: High effi ciency particulate air (HEPA) fi ltered rooms are generally recommended in hematopoietic stem cell transplantations (SCT), especially for those allogeneic. In some transplant centers, however, the HEPA fi ltration is not available. Literature data comparing the incidence of pulmonary and bronchial infections in HEPA or non-HEPA fi ltered rooms are rare. The East Forum EBMT-NG has been conducting an observational study since 1/2010 to get more information about this issue. Assumption: SCT may be safely performed even in non-HEPA fi ltered rooms. Objectives: To analyze the incidence of pulmonary and bronchial infections in respect to HEPA or non-HEPA fi ltration available in the transplantation rooms. Methods and Patients: Observational, prospective, multi center study focused to the East European BMT centers. Patients undergoing the autologous or allogeneic SCT will be enrolled into this observation consecutively and every transplanted patient in a BMT center will be registered. Defi nitions: Pulmonary or bronchial infection=clinical sings of pulmonary or bronchial affection (i.e. cough, dyspnoe) or radiological changes (RTG, CT) together with elevated body temperature and/or CRP. Monitoring: Specifi c pre-printed monitoring card is designed for the data recording. The observational period starts on a patient´s admission and fi nishes on day +100 post-transplant. Interim results: 446 patients (244 males, 54%), median age 52 (16-70) have been registered into the study in 1/2010-10/2011, so far. 7 centers are active in cooperation. Diagnose: myeloma 31%, AML 22%, NHL 15%, ALL 9%, Hodgkin 5%, CLL 3%, MDS 3%, other 12%. Transplantation: autologous 51%, allogeneic 49%, HEPA fi ltration in: autologous 64%, allogeneic 90%, neutropenia duration 9 (3-31) days. Infections: pneumonia 26/446 (6%), bronchitis 8/446 (2%), onset on day 11 (-2-75), HEPA fi ltration in 27/34 (79%) patients, AutoSCT in 15/34 (45%) and AlloSCT in 19/34 ( 55%) patients, 13/26 (56%) recovered from pneumonia. Discussion: larger numbers of patients are needed before any fair results can be made. This study is conducted and focused to East European BMT centers in an effort to help support mutual regional cooperation. Objectives: Hematopoietic cell transplantation (HCT) is a potential curative therapy for various hematologic disorders. Hematopoietic stem cells are usually transfused through a Central Venous Catheter (CVC), which could serve as a potential portal of entry for microorganisms to colonize and multiply, inducing catheter-related blood stream infection (CR-BSI). We had observed a high rate of CR-BSI at the Bone Marrow Transplantation (BMT) Unit of the American University of Beirut (AUB) Medical Center. Several interventions had been implemented to control the situation such as proper handling and manipulating of CVC, limiting manipulation to certifi ed and competent nursing staff, and ensuring aseptic standard technique during CVC insertion procedures. Despite these attempts, CVC infection rate remained high with no obvious reasons. Accordingly, we implemented prophylactic use of a relatively inexpensive broad spectrum antibiotic, namely doxycycline, at a dose of 100mg orally twice/day started on all adult BMT patients on the day of transplant till the day of CVC removal. We hereby aim at investigating whether administration of doxycycline prophylaxis reduces CR-BSI rate compared to historic before introducing doxycycline. Methods: From October 2009 to October 2011, data was collected retrospectively on 54 consecutive patients, 26 of whom received doxycycline (doxycycline group), and 28 of whom did not receive doxycycline (control group). Collected variables included demographic and characteristic data (age, gender, type of transplant, primary diagnosis), CVC infection status, and type of cultured microorganism. AUB Institutional Review Board approval was obtained. Results: The groups were comparable in terms of age, recipient gender, type of HCT, primary diagnosis (Table 1) . No CVC infection (0%) in the doxycycline group, while 5 infection episodes (18.5%) in 4 patients in the control group were detected, a statistically signifi cant difference (p < 0.001). The median time from CVC insertion and blood sampling for culture was 17 days (Range 10-21). Episodes of CR-BSI were due to: Escherichia coli=1, coagulase-negative Staphylococcus spp (CNSS)=3, both Escherichia coli & CNSS=1.
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Conclusion: CR-BSI was reduced signifi cantly after introducing doxycycline prophylaxis. This study supports systemic use of doxycycline as a prophylactic strategy for preventing CVC infection in adult BMT patients. A randomized controlled study is warranted to confi rm these fi ndings. Context: The hospitalization of a child has an impact on is schooling. Most patients are abruptly taken out of school after the diagnosis has been made, which results in a loss off stability and reference point. We know that the social and emotional development of children is formed at school though their relationships with their friends. In addition studies confi rm that there is an increase in school failures with chronic illness. The child is penalized twice. Aims: To keep in contact with the child's school to optimize the learning. Help hospitalized children keep bearings and foster links with their peers and teacher.
P1277
Optimize the return to school. Involve the child in hospital and their friends in a common project. Method: Make available laptop computers with webcam for the patient and the teacher. The connection between the child and his class is made with an application through "skype" using video images and text. The time's connection is scheduled by the hospital teacher and the child's school teacher who together will have previously planned a pedagogical program. The hospital teacher supervises children in this process.
Results: Experience has shown us that this service improves the quality of life of a hospitalized child. Hospital becomes a "place of life" for children having long hospitalization, like the transplantation. It is essential that the child is not desocialized. It is a supplementary tool for teachers and nursing to keep contact between the child and the school. The hospitalized child stays a learner, like any other child of his age. He learns same subjects as his school mates and this helps to decrease the school failure.
P1279
The impact of haematopoietic stem cell transplantation on sexuality: a systematic review of the literature K. Thygesen (1) We review evidence concerning the impact of hematopoietic stem cell transplantation (HSCT) on sexuality. The aims are to determine; (1) the sexual changes experienced by patients following allogeneic or autologous HSCT and its consequences; (2) changes in the sexual function over time; and (3) the impact of physiological changes induced by intensive treatment with radiation and chemotherapy on sexual functioning. Four databases were searched for articles published between January 1995 and May 2011. A total of 14 studies were identifi ed and analyzed. We found that (1) multiple aspects of sexuality were affected and the impact and etiology of these sexual alterations were different between genders and (2) recovery of sexual activity and pleasure occurred in the fi rst two years after HSCT, although it appears that some survivors are more likely to experience sexual dysfunction even 5-10 years after HSCT compared to controls, (3) there was contradictory evidence concerning possible differences between allogeneic and autologous HSCT, though there was a signifi cant relation between the sexual dysfunctions and the type of chemotherapy administrated as conditioning and chronic GVHD. Future prospective research in sexual dysfunction with specifi c reliable validated instruments and more adequate sample sizes will be required to defi nitively evaluate the impact of HSCT on sexuality.
P1280 'From Spike to Needle': an audit of antibiotic response times for febrile neutropenia S. Hunter University College London Hospital (London, UK)
Objectives: The purpose of this audit was to identify whether haematology/BMT inpatients were receiving fi rst line antibiotics for febrile neutropenia within a maximum of one hour as per unit policy. Methods: A pilot audit was undertaken to test the audit tool. During the main audit, data from 68 patients (86 febrile neutropenic episodes) was collected during a 10 week period (AprilJune 2011). Data was collected on speed of review, initiation of antibiotics and outcome. Results: Data was analysed to examine how long patients waited to be reviewed by a doctor and how long it took for the administration of antibiotics. The fi ndings showed that there was often a delay in the administration of antibiotics. 46% of patients received antibiotics within the hour, with several patients waiting more than two hours. Analysis of time to medical review showed that 41% of patients waited more than one hour with 8 of these patients waiting over two hours for clinical review. Prescription to dispensation delays were also noted but were not quantifi able due to inconsistencies in documentation. Discussion: A number of factors contributed to delays in treatment including a shortage of doctors, especially at night. As a result of this audit measures are being initiated to improve the speed of administration of antibiotics. These include the initiation of Patient Group Directives enabling nurse initiation of fi rst-line treatment; modifi cation of documentation to ensure response times are easier to identify in future and updated education of medical and nursing staff. Conclusion: There was a signifi cant delay in time to receiving antibiotics in patients with febrile neutropenia. This was multifactorial however delay until medical review was found to be a signifi cant factor. Full details will be presented. We recommend that all BMT/Haematology wards monitor antibiotic response times routinely.
P1281 Central venous catheter bloodstream infections: from knowledge to practice AL. Graca IPO (Lisbon, PT)
Healthcare institutions and their patients are familiar with the effects of Nosocomial Infections (NI). These consequences translate to the increased suffering and extension of recovery time for the patients and diminished indexes of quality among institutions. Central Venous Catheter (CVC) related bloodstream infections are costly and account for a signifi cant proportion of hospitalacquired infections. Patients submitted to hematopoietic stem cell transplantation are an exceptionally high-risk group considering their illness and severity of treatment, which demands a CVC. The safety of the patients concerning this device depends mostly on the nursing care.
To help reduce the incidence of this complication it is imperative to know the pathogenesis and patient related risk factors, as well as to apply the international guidelines of Infection Control Prevention. The aim of this investigation was to assess current practice and staff knowledge of CVC post-insertion care and therefore identify aspects of CVC care with potential for improvement. With the help of two methodological validated instruments (questionnaire and a procedure check list) it was possible to assess the attitudes and practices of the nurses handling the CVC at the Hematopoietic Stem Cell Transplant Unit in Instituto Português de Oncologia de Lisboa. Conclusion: it was shown that positive attitudes and practices are those concerning nail care, the use of 70º alcohol to disinfect the connecting valve, the use of a sterile dressing to protect the insertion site and the change of administration sets every 24h when blood products and lipidic solutions are infused. It was also found that there are technical details that can be optimized such as the use of 2% chlorhexidine gluconate to disinfect the insertion site, the use of a single line to infuse blood products and lipidic solutions and hygiene in the post-handling procedure.
The reduce the rates of CVC bloodstream infections a multiple approach includes updating protocols and developing educational strategies with an emphasis on specifi c problems observed during a careful evaluation of CVC care practices. The conclusions of this study highlight the importance of increased awareness among practitioners to improve healthcare safety.
P1282
Is it necessary to process a large blood volume to collect suffi cient autologous peripheral blood stem cells? Introduction: The fi nal number of CD34+ peripheral blood stem cells that is obtained after mobilization and subsequent collection is determined by the number of CD34 + cells in the peripheral blood as well as the effi ciency of the collection procedure. The latter can vary between different patients and/or apheresis machines, but in our department a median of 40% effi ciency is reached with the Spectra Optia and Cobe Spectra (Caridian BCT). In general 15 liters of peripheral blood are processed, which takes about 5 hours. A minimum of 5x106 CD34+cells/kg is considered suffi cient. The question we asked ourselves was: Can we process less than 15 liters TBV (=Total Blood Volume) by using the CD34 + cells pre-count and a median effi ciency of 40% to collect a minimum of 5x106 CD34+cells/kg recipient? Methods: In this study 92 patients were included. Diagnosis: 3xAML, 50xMM, 31xNHL, 6xHL, 3x Amyloidosis. All patients gave consent for the mobilization and collection of peripheral blood stem cells. All patients were mobilized with G-CSF 5 μg/kg twice daily, 5 to 10 days. In addition Plerixafor 240 μg/kg sc was given to 5 patients. For 112 procedures a prediction of the number of CD34+ cells was made based on the pre-count CD34+ cells in Peripheral Blood (=PB) and a collection effi ciency of 40% with use of the formula below. Formula:
Liters TBV processed × CD34+ PB ____________________________ × 40% (0.4) = predicted collection CD34+/10 6 /kg Bodyweight (kg) receiver Results: 21 patients needed 2 procedures, 70 patients needed 1 procedure. The processed liters TBV are between 3,3 liters and a maximum off 15 liters. In 36 of the procedures there has been less than 10 liters processed, all those patients had a collection off at least 5 x 10 6 /kg bodyweight of stem cells with effi ciencies between 32% and 87% median: 52.96%. In Conclusion: The outcome off this study shows that it is possible to process less TBV to collect suffi cient stem cells for transplantation, by using an effi cient pre calculation. This has the following advantages: 
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Adopted by National patient safety agency as The Matching Michigan project Health Care Trusts in the UK have formalised the insertion, handling, accessing, and removal of CVC's in the critical care setting. Our patient group all require CVC use and in May 2011 the Children's BMTU in Newcastle was invited to join our critical care colleagues in auditing the incidence of blood stream infection. We used the tool devised for critical care with several important changes appropriate to our speciality to alert us promptly to the incidence of infection in children under going HSCT transplant. The CVC's we use in our practice are different from those used in the intensive care setting and the BMT patients are usually more likely to handle and contaminate their catheters as they are awake and conscious and as children or infants are unlikely to obey instructions or respect boundaries which would protect and preserve the catheter integrity. Involvement in this project has given us a mechanism to critically evaluate our practice on a monthly basis and both investigate, analyse and review any issues in our vulnerable patient group to:
• pin point problems, • consider comparisons, • seek solutions.
Whilst this project is in its infancy this presentation will discuss the method used to identify problems and our progress to date using a patient event to illustrate the process. Aim: This service evaluation aims to evaluate CVC bacterial stream infection (BSI) rates in a specialist haematology and SCT unit and to see if the implementation of BD PosiFlush™ a pre-fi lled saline fl ush reduces the incidence of BSI. Methods: All patients admitted to the unit with either Hickman or internal jugular (IJ) lines, were considered for the service evaluation. Patients were followed through the inpatient stay during the study period. The control group used manually drawn saline fl ushes. The sample group used BD PosiFlush™. The sample size was 28 and 27 patients respectively. The patients were monitored clinically for signs of infection. Data was analysed using 2X2 Chi squared and Fishers exact test. Data was also collected on raw material costs, nursing time and cost for waste disposal.
Results: The data clearly shows:
• A decrease in the number of septic episodes from 22 in the control group to 18 in the BD PosiFlush™ group.
• A slight increase in the episodes of sepsis of unknown origin from 12 in the control group to 14 in the BD PosiFlush™ group.
• A signifi cant decrease in the number of BSI from 10 in the control group to 4 in the BD PosiFlush™ group. (2 × 2 chi squared p=0.0318, Fishers Exact p=0.055).
There was a notable saving in nurses' time from 57.1 seconds for manual saline fl ushes to 4.45 seconds for BD PosiFlush™. This represents a potential cost saving when reduced manpower and waste are taken into consideration. Conclusion: It was felt the borderline statistical signifi cance was due to the small sample group. A repeat service evaluation has now commenced. were removed due to an infection. and 1due to occlusion (3.52 for 1000 catheter days).60% went through BMT treatment, 15% were neutropenic at the time of insertion. 13 out of 20 catheters had been inserted for the fi rst time. 3 Catherters were removed within 10 days from insertion. 13 nurses were observed, fi ndins point on: not using sterile technique, not performing hand wash, unclean treatment environment, lack of documentation. Conclusion: Removal rate was similar to the literature, but still on the high scale not as the. BMT patients need extra care due to high percentage of catheters infection. There is need to improve patient care guideline to prevent cross infections, and to improve hand wash habits. Over all there is a need for computerized data collection which can provide ongoing feedback to improve the care and outcomes of patients with Central Catheters.
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P1286 Central venous catheter-associated nosocomial infection M. Ruiz Seixas, L. López Rodríguez Hospital Universitario Virgen del Rocio (Sevilla, ES)
Nosocomial infections pose a serious problem for the health system as they increase morbid-mortality rates, mean hospital stays and costs, apart from the harm they do to both patients and family. Central venous catheter-associated infections have a high incidence. Figure 1 shows the details. 31% (n=22) of the 71 patients included in the study presented with complications associated with the use of the catheter. 26.8% (n=19) due to infectious causes, 1.4% (n=1) suffered with deep vein thrombosis, another 1.4% (n=1) underwent catheter displacement and another 1.4% (n=1) suffered catheter fracture apart from infection, as shown in Figure 2 . The 11.3% (n=8) presented with local infection, 5.6% (n=4) with systemic infection and 16.9% (n=12) with catheter colonization.
In our sample we detected four cases of catheter-related bacteraemia, being 0.15 per 1,000 catheter-days the usual rate of CVC-associated systemic infection.
Conclusion:
The patients analysed showed 28.2% of catheter-associated infections. No infections were observed in relation to catheter insertion. The incidence of systemic infections associated to CVC is 0.15 per 1,000 catheter-days.
The most common complications associated with catheter insertion are bleeding and brachial plexus injury. Conclusions: There is evidence of catheter removal before confi rming blood cultures as the culture from the tip of the catheter is negative in the majority of cases. A suspected diagnosis of Catheter-related Bacteremia and its complications entails adopting a series of therapeutic attitudes which depend upon the clinical state of the patient, taking into account that some decisions are erroneous. In our study, a high level of displacements, disconnections and/or breakages was observed in the catheters, which leads us to think that the method of attachment is not appropriate.We consider standardized prospective monitoring to be necessary in order to evaluate this type of infection.
P1288 Patient safety in medication; a retrospective inspection of reported errors and near misses M. Stenvall Helsinki University Central Hospital (Helsinki, FI)
This development work is part of Patient safety studies (30 ECTS) in The Patient Safety and Learning Center of Arcada in Helsinki Finland. These studies will be fi nished by spring 2012. Children's hospital K10 Division of Haematology-Oncology and Stem Cell Transplantation is combined with several units. There is the paediatric transplant unit (10 beds, JACIE accreditated since 2008), haematology/oncology unit offering conventional treatment (9beds), day-hospital, outpatient unit, home care, anaesthesia unit (BM biopsies, lumbar punctures) and hsc collection unit. Physicians and nursing staff is working in all these units after specifi c training. There are 6-7 paediatric haematologists, 1 anaesthesiologist and nearly 70 nurses. There is a pharmacologist in both wards. All the patients have inserted cvc's (transplant patients have 2 catheters with one or two lumens). Procedure for handling patient safety incident reports has been in place since 2006. There has been a web-based patient safety incidents reporting system (HaiPro) since 2009. Reports are gathered every 3 months and discussed in division's management group (medical and nursing lead present). In these meetings is also decided actions to be taken and information to the staff. This is a no blame practice. Retrospective inspection of reported errors and near misses from the HaiPro-system (9/2009-9/2011) will be done. HaiPro web-based reporting system allows one to choose from 5 subgroups when making the report from medication error (preparation, prescription, documentation, distribution, administration and unexpected reaction for the medication). All subgroups are more detailed and allow one to be more precise. There are approx. 90 error reports made yearly, out of which more 50% are related to medication.
Reporting the results of this retrospective inspection of medication errors and near misses: total number of medication errors, how these errors are divided in different subgroups, what action has already been taken and possible impact to the reported errors. It will be also discussed if new interventions are needed? Follow up after ½ months after intervention, which will take place in autumn 2012. 
P1289 The tunnelled central catheter initially inserted for induction therapy in patients with
P1290 Venous access for apheresis and photopheresis procedures
A.b. Babic, R. Elezi, L.O. Orlando, D.L. Laszlo, G.A. Andreola, L.M. Morabito,
.G.M. Martinelli European Institute of Oncology (Milan, IT)
Background: Our Clinical Transplantation Program consists in a process performed by a multidisciplinary team working with common staff training,programs,protocols and quality management systems according to JACIE and ISO guidelines.Peripheral blood stem cells represent the most used source of hematopoietic cells and apheresis is a routinary technique applied to collect them.In our Collection Unit we use Cobe Spectra System for apheresis procedures and also perform photopheresis (ECP) procedures with UVA-PIT off line system for GvHD treatment. Aims: To perform the apheresis pocedures,we need the presence of good vascular access,able to provide constant blood fl ow pressure during the whole procedure time with minor complication risks,due to the procedure or to a long time presence of central venous catheter.
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Methods: For apheresis procedures to collect CD34+ cells or lymphocytes, where possible, we prefer to use the peripheral veins (cephalic or basilical) for the procedure. On the contrary, in patients the peripheral veins are often insuffi cient or severely compromised by multiple chemotherapy cycles, therefore we need to use central veins. Frequently our patients are provided with a Porth-a-Cath catheter which can be used as a return way so it becomes easier to fi nd only one peripheral access rather than two. In case of complete absence of peripheral access we insert central venous catheter preferably in femoral vein. When we perform the ECP procedure with off line system we fi rst need to execute the lynfo+mono collection by Cobe Spectra; therefore we need two good venous access available during the whole program of cure. There are a variety of schedules depending on disease but usually the treatment takes 5-6 months to be completed. Usually we use double lumen tunnelled, 12,5 FR catheter for dialysis and leave it in situ for more then 6 months. Results: Depeding on procedure (ECP, apheresis), the choice of the catheters to be used is personalised. Venous access, risks of infections and thrombosis, scheduling of catheter's medications are evaluated by the apheresis nurses. Complications due to catheters used for apheresis procedure are usually rare, mostly those linked to thrombotic or infection complications. Conclusions: Choosing the right venous access we can guarantee the optimum blood fl ow able to collect in less time the selected cell types with low contamination and risks and major security to patients and operators. She then underwent 6 cycles of chemotherapy including antracycline, cyclophosphamide, vincristine, procarbazine and prednisolone which was followed by mantle and inverted Y-fi eld radiotherapy until June 2010. All these treatments has been performed by using peripheral veins. During the treatment she developed Herpes Zoster and Parvovirus infection treated respectively with antiviral drugs and Ig ev. In August 2010, a CT scan showed relapse of disease. She was inserted the Gronshong central catheter and on October 25th, she underwent the fi rst cycle of chemotherapy with ifosfamide, etoposide and prednisone and on November 2nd she was admitted in our inpatient department. Objectives: We wanted to use this chemotherapy cycle as "mobilization" adding GCSF to see if we are able to collect her stem cells for autologous transplant and eventually using plerixafor on demand. Methods:We followed her blood cell counts recovery, monitoring circulating CD34+ as soon as white blood cells reached 1000/ul, but counts showed very low numbers, only 2 cells/ul at 11th November. We therefore decided to add plerixafor and the very next day she had 10 cells/ul of CD34+ and we positioned a central venous catheter in the femoral vein. Results: we perform the fi rst apheresis procedure permitting her to achieve 0.7 x 10 6 cells/kg at the very day (12 November). We therefore administered a second dose of plerixafor and repeated the procedure the day after with 19 cells/ul and a collection of 1.5 x 10 6 cells/kg, for a total of 2.2 x 10E 6 CD34+/kg. Therefore she underwent two additional cycles with ifosfamide, carboplatin and etoposide therapy and achieved a complete response PET and CT scan documented in January 2011. She underwent the autologous stem cell transplantation after a conditioning regimen according to BEAM schedule and in February 2011 PET and CT scans confi rmed the complete response. Conclusions: Use of plerixafor in combination with GCSF is safe and effi cacy procedure and permits the mobilization and collection of adequate CD34+peripheral cells also in adolescent patients.
P1291
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The Introduction: Every two years the Erasmus MC conducts a survey into patients' satisfaction with their care. After reviewing the results of this survey the Erasmus MC's oncology centre decided further investigation was needed in order to gain a better understanding of patients' experiences and opinions. A literature study was conducted and revealed that the best method to maximise information provided by patients for improving the quality of care is the focus group method. Method: Nursing staff from various specialties within the oncology centre participated in a training program "patient participation" using the focus group methodology. The training consisted of several modules, the aim of which was to provide the participants with the knowledge and skills to be able to translate the obtained survey results into improvements via the so-called (Plan-Do-Check-Act) PDCA improvement cycle. Within the training program the focus group methodology was applied to patients from the Haematology Department with the theme 'aftercare'. This pilot focus group was evaluated and presented in the oncology centre. Results:
-A working group, organization wide, formed with members trained in the focus group methodology has been created. This expertise can be used to investigate various themes in different departments, using the expertise and experience of patients. -The 'aftercare' pilot has provided information relevant to improving the care within the haematology department. -Through the cooperation of various departments within the Oncology Centre the project contributes to, 'cooperating and connecting', one of the pillars of the vision of the Erasmus MC.
Conclusion: By implementation of the focus group methodology as a structured and uniform method of patient participation within the various departments of the oncology centre, the unique expertise of the patient (opinions and experience) can be obtained. This can be used to implement improvements in the quality of care. It is recommended to use the focus group expertise available once a year and to apply it to a specifi c topic in depth.
P1293 Evaluation of the concept insertion of the central venous catheter for admission of the allogeneic stem cell transplantation in the SCT-ward of university hospital, Zurich W. Rutz, K. Pötzsch University Hospital Zurich (Zurich, CH)
Introduction: At the beginning of 2009 we created a work group and revised the concept central venous catheter (CVC) insertion. The former routine of the entire day of admission has been ineffi cient. It was often necessary to wait until night time to receive the appointment for the catheter insertion. Because of that the staff's resources couldn't be used appropriate. The patients couldn't organize their day, this makes them unsatisfi ed. The patients did often not receive the desired catheter. These survey serve us as a reference point, revealing how close we have come to our goal or weather we have to change our procedure. Goals:
-to use the personal resources as well as possible -the patient is satisfi ed -the adviced CVC will be inserted on the admission day -good collaboration with the intense medical service -the nurse will assist the CVC insertion.
Method: We created serveys and every patient since 2009 who has received a CVC under our assistance has been notifi ed. We send 82 questionnaires, and 63 patients responded. We posed the question, weather they were satisfi ed with our concept. We also handed out 17 questionnaires to our staff members to fi nd out, which experiences they have. 16 staff members completed the questionnaire. Results: Evaluation of the patients survey: All patients, except one patient, have been informed well about the CVC insertion. The CVC (with one exception) could be inserted on the day of admission. Evaluation of the nurses survey:
We received lot's of interesting opinion and proposals from our colleagues. The majority of the employees think, the patients benefi t from their accompany during the CVC insertion and their assistant. Conclusion: We will go on with our new concept, because the responses of the patients and staff encouraged us. We will use the critical inputs to improve our concept, to optimize the admission day.
P1294 Thrombotic obstruction related of central venous catheter in patients submitted to haematopoietic stem cell transplantation K.M.B. Arone (1), L.M. Garbin (1), P.E.D. Reis (2), C.M. Galvão (1), R.C.C.P. Silveira (1) (1)University of São Paulo (Ribeirão Preto, BR); (2)University of Brasilia (Brasilia, BR)
Patient submitted to hematopoietic stem cell transplantation (HSCT) needs indwelling and semi-implanted central venous catheter (CVC). Thrombotic obstruction related of CVC, however, is a complication that can lead to the inadequate functioning of the intravascular device and its early removal. This integrative literature review aimed to summarize measures for the prevention and treatment of thrombotic obstruction related to indwelling and semi-implanted CVC, in patients submitted to HSCT. The sample included seven primary studies, with two randomized clinical trials, three cohorts and two case series. As for the theme categories, four studies discussed CVC-related thrombotic obstruction prevention measures, two addressed treatment measures and one prevention and treatment measures. Among the studies that discussed prevention measures, one single research showed effective obstruction prevention, which was a cohort on the use of oral warfarin, started on the day the central venous device was inserted. The other studies showed no statistically signifi cant differences between standard treatment and the tested intervention. Regarding treatment measures, three studies showed to be successful: one appointed the effi cacy of streptokinase or urokinase use, another showed the benefi ts of using low molecular weight heparin and the third successfully treated the obstruction with heparin and urokinase. The restricted evolution of research regarding CVC patency was observed, which did not accompany the evolution of HSC therapy, mainly regarding nursing care, as all addressed discuss medication interventions, without discussing non-medication aspects, such as the fl ush volume and frequency with saline solution, description of positive pressure technique, ideal syringe size, pressure exerted during medication infusion and catheter lumen sealing devices with positive pressure. These results show the need for further controlled studies to test nursing interventions in the prevention of catheter-related thrombotic obstruction.
P1295 Survey GITMO on oral food intake in patients with gastrointestinal GvHD L.O. Orlando, G.P.. Gargiulo, F.a. Alberani on behalf of GITMO (Gruppo Italiano Trapianto di Midollo Osseo)
Aims: Identify different oral food intake strategies of GITMO centers in managing patients with gastointestinal aGVHD. Compare different oral food intake strategies in gastointestinal aGVHD with International guidelines.
[P1295]
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Outline new educational messages. Methods: Two meetings were held prior to the merger between patients, nursing staff, doctors and service and project managers. Patient representatives from both trusts were invited and were given the opportunity to participate in the meeting. The fi rst meeting was a discussion of patients concerns, issues and anxities they had prior to the merger. The second meeting was held at the beginning of September, shortly before the merger of services on the 27th September 2011. The meeting re-visited the concerns, issues and anxieties with answers and resolutions. But also an opportunity to raise further issues. Results: A number of issues, need and concerns were raised at the fi rst meeting. These were transport issues incuding pubic transport facilities, parking, pharmacy facilities and opening hours, clinic appointments, facilities and capacity, structure of the clinics and wards. Before the next meeting, much time was spent by the teams looking into the various areas and positive feedback was given regarding the concerns, needs and anxieties to patients. Conclusion: Following the successful merger a further meeting has been organised for January for the Patient Involvement Group. This will continue the work of looking at patients concerns and any areas that can be improved following the merger. The multidisciplinary approach and patient involvement group's inclusion to the merger appears to have had a positive effect, given the patient a voice and lead to important changes being made to a leading Bone Marrow Transplant service. -Until now 49 patients are transferred.
P1297
-Number of patients is still increasing.
-Patients expressed themselves very satisfi ed.
-Patient satisfaction/participation investigation will follow.
-For the future, audits will be done between centers. It is an ongoing process to make the procedures more effi cient and thereby ensure the quality and continuity. -Continuous training and education of nurses is required.
P1298 Pain, a joint care! E.J.M. van Huizen-Almering LUMC (Leiden, NL)
Introduction: The Short stay unit is intended for adult patients with an internal disease arriving for therapy or research in day care, an outpatient treatment or a short hospitalization with a maximum duration of fi ve days. Patients with a hematologic-oncological disease arrive for care in a diagnostic, curative, adjuvant, neoadjuvant or palliative setting. We see patient before and after the bone marrow transplantation. The unit works closely together with the Bone marrow transplantation/Hematology unit. Literature shows that the prevalence of pain by cancer patients is high. Cancer pain is far reaching and affects the daily functioning of the patient. With pain being one of the most feared symptoms. At the Short stay unit the care for pain is not optimal organised. Method: The question "How can we improve the care for the pain by cancer patients on the short stay unit in the LUMC wherefore it is better structured and takes place unambiguously?" was central in literature study. By personal observation and conversations with colleagues bottlenecks have been analyzed. The following recommendations are made for improvement: 1) Introduction of the NRS (numeral rating scale) pain measurement instrument. 2) Introduction of a pain history. 3) Unambiguous communication by nurses. Contact is made with the pain clinic, doctors and various hospitals. The conference of the VMS (safety management program in the Netherlands) on pain has been visit. Results: After the introduction of the improvement plan at the team meeting it was decided to form the working group pain from where the improvements will be designed and coordinated. In cooperation with the pain clinic, the clinical course is designed. This course is necessary to increase the knowledge of nurses on pain and to the implementation of the NRS.
Cooperation with the working group information and diagnostics is taking place for designing improvement two and three. Conclusion: By using a pain measurement instrument, pain is objectively measured. Measuring is knowing. A pain history makes the pain problem clearer. Along with clear information, it ensures that at the Short stay unit, we approach the pain by cancer patients structural and unambiguous. Results: In the group of patients that received the new antiemetic prophylaxis days of admittance was reduced from 25 days to 22 days. Number of days with reported vomiting was reduced from 6,7 days to 4,6 days and the number of days with nausea was reduced from 20,7 to 16,3. Patients with a start of CINV within 24 hours (acute CINV) from start of conditioning were reduced from 68% to 31%. Patients with the highest grade (grade 3) of vomiting were reduced from 18% to 10% and patients with the highest grade (grade 3) of nausea were reduced from 34% to 17%. The use of TPN was reduced from 16,2 days to 12,4 days. Conclusion: The changes in antiemetic prophylaxis showed a better control of acute CINV. A reduction was seen in the days of admittance, days with CINV, grade of CINV and the use of TPN. Even though modern antiemetic drugs are available, many patients still suffer from severe problems with CINV. Further research is needed in this fi eld, to in the best way, be able to use the antiemetic drugs available, especially in the group of patients receiving high dose Melphalan.
P1299
P1300 Should we transfuse or not transfuse? S. Vieira, D. Monroe The Trustee of London Clinic (London, UK)
Introduction: Blood transfusion continues to be an essential part of modern practise but it is not without risk. During the last decade there has been an increased interest across the United Kingdom (UK) and Europe for collecting data on the hazards of transfusion of blood components. Therefore avoiding unnecessary transfusion is accepted as one way of reducing the risk, which is associated with blood transfusion. In our stem cell transplant unit we have audited red cell transfusions. Our unit policy is to keep the haemoglobin level above 8g/dl, this may change from time to time and depends on the patient's clinical condition. Method: The audit was carried out prospectively and retrospectively. A "log in" book was kept in the Unit for recording the red cell transfusion orders. The data was validated and cross checked retrospectively, all inpatient data was recorded on a monthly basis. The audit was carried out over a period of 17 months from May 2010 until end of September 2011. The data was divided into two periods, outcome data was compared within these two periods. Result: During period II (13 months) a total of 240 episodes RCT were performed in our unit. Haemoglobin levels were 8.5 g/dL or below in 86.4% episodes. Where as 75.5% period I (See Table I ), only 8.2% of the transfusions were where the haemoglobin level was 9.1g/dL or above. The main reasons for transfusion when Hg > 10.1 g/dL were associated with the protocol regarding hyper transfusing beta thalassemia major patient prior to transplant. The reason for transfusion was categorised as: routine, unit protocol, bleeding, pre procedure and on doctor's instruction due to patient symptoms or keeping a high thresh hold haemoglobin level. Routine RCT were 52.7% of total episodes in period II, where as in period I, routine transfusions were 22.5%. However 8.2% of the RCT transfusions were given when haemoglobin levels were 9.1 g/dL or higher in period II. The fi gure was 10% in period I. Conclusion: Our organisation recognises the importance of risk associated in unnecessary blood product transfusion. Our 17 moths audit has shown interesting fi gures. The audit was divided into two periods and outcomes compared. Our fi gures showed that practice is improving. In period II, 8.2% of total RCT episodes were given as routine were above 9.1 g/dL where as 83.3% of routine RCT were performed due to low haemoglobin level according to our unit policy.
P1301 Can platelet transfusion be unnecessary? S. Vieira, D. Monroe The Trustee of London Clinic (London, UK)
Introduction: Blood transfusion continues to be an essential part of modern practise, but it is not without risk. During the last decade there has been an increased interest across the United Kingdom (UK) and Europe in collecting data on the hazards of transfusion of blood components. Therefore avoiding unnecessary transfusion is accepted as one way of reducing the risk, which is associated with blood transfusion. In our stem cell transplant unit we audited platelet transfusion (PT). Method: The audit was carried out prospectively and retrospectively. A "log in" book was kept in the Unit for recording the platelet transfusion orders. The data was validated and cross checked retrospectively, all inpatient episodes were recorded on a monthly basis. The audit was carried out over a 17 month period from May 2010 until the end of September 2011. The duration was divided in two periods in order to compare the outcome with our initial audit. Period I: 01/05/10-31/10/10 Period II: 01/11/10-30/09/10 Result: Our unit policy is to keep the platelet count at circa 10X109 / L for uncomplicated inpatients and at circa 20 x 10 9 /L for complicated patients and outpatients. We also aimed to keep platelet above 50 x 10 9 /L if patient is receiving anticoagulant or bleeding for various reasons. In Period II, over 13 months, a total of 313 episodes of platelet transfusion occurred. 63.6% of these were where the platelet count was below 20 x 10 9 /L; where as in period I, this fi gure was 36.5%. In period I, 45.5% of platelet transfusions took place when platelet count was 31 x 10 9 /L or above, where as in period II this fi gure had dropped dramatically to 21.1%. The reasons for unusual transfusion were bleeding, prior to invasive procedure and anticoagulant use.
[P1300]
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Conclusion: Our organisation recognises the importance of risk associated in unnecessary blood component transfusion. Our 17 months audit has shown interesting fi gures. The duration of audit was divided in two different periods and outcomes compared. Between these two periods there were dramatic changes as Table II shows. Our fi gures dropped rapidly from 45.5% to 21.1% in platelet transfusion when the platelet count was higher than 31 x10 9 /L. There were various reasons to transfuse platelets even though the count was reasonable for the haematology patient group such as: bleeding, prior to invasive procedure and anticoagulant use.
P1302
Constipation among HSCT patients: incidence, severity and risk factors M. Ben-Izhak, A. Galitzer, A. Naydich, R. Radiano Hadassah Medical Organization (Jerusalem, IL) Introduction: HSCT patients are at risk of developing constipation due to a combination of various risk factors, including high dose radiotherapy and chemotherapy, extensive use of opiates, electrolyte imbalance, extreme weakness and reduced mobility. In addition, severe nausea and vomiting during the transplant process, followed by a reduced appetite, has a direct infl uence on the nutritional status of the patient. During the transplant process a constipated patient is at risk of infection due to skin integrity damage in the neutropenic phase. Moreover, constipation treatment options are limited to drug therapy due to thrombocytopenia. The study aimed to examine the incidence and severity of constipation among HSCT patients and to identify risk factors, in order to formulate an evidence-based intervention plan that would contribute to patient quality of life and general wellbeing. Methods and Interventions: Fifty HSCT patients were recruited over one year. Each participant received a set of four questionnaires at three different time points: upon admission before transplant; a week after during the nadir; and three months post discharge during a follow-up visit to day care. The questionnaire set included evaluation of constipation severity, evaluation of risk factors, questions regarding their disease and treatment and demographic details. Results: Preliminary results show that the risk of constipation signifi cantly increased at the second time point, as did the rate of constipation found, when compared to the other time points in the study. Additionally, a statistical signifi cance was found between medication and the rate of constipation at the second time point, correlating with the literature reviewed. Women reported a higher risk of constipation compared to men, and the actual rate of constipation among women was higher, particularly at the fi rst time point. Conclusions: Since there exists very little literature regarding constipation among HSCT patients, we deemed it very important to explore this basic nursing challenge, in order to optimize symptom management during the prolonged transplant process. Early results indicate that constipation does in fact exist among HSCT patients, particularly post-transplant, during their complicated hospital stay. The study fi ndings have the potential to be the basis of specifi c treatment programs to promote quality of care through optimal symptom management.
[P1301] P1303 Evaluation of oral mucositis in children receiving supersatured calcium and phosphate solution during high-dose chemotherapy with autologous stem cell transplantation S. Lalioui, S. Rodrigues, P. Usubelli, D. Valteau-Couanet, C. Dufour Institut Gustave Roussy (Villejuif, FR) Objective: Oral mucositis (OM) is a frequent side effect in children receiving high-dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT). The objective was to validate a new paediatric evaluation scale to determine OM incidence in patients receiving supersatured calcium and phosphate mouthwash solution. Methods: 30 patients (16 with neuroblastoma, 8 with brain tumour, 1 with Hodgkin lymphoma and 3 with Ewing sarcoma) received supersatured calcium and phosphate mouthwash solution, 6 times daily at initiation HDCT with ASCT. The nurses evaluated daily the patient's compliance to mouthwash and the severity of OM according to the new evaluation scale: method of mouthwash; tolerance and compliance of mouthwash; grade of OM according to OMS scale; mouth pain; total dose and duration of parenteral opioid analgesic use; and incidence and duration of total parenteral nutrition administration. Results: Two patients presented vomiting and the supersatured calcium and phosphate mouthwash was stopped. In the 28 patients, the methods of mouthwash were often combined. In 26 patients, the compliance of the mouthwash was good and 12 patients developed grade III-IV OM. The 2 others patients had bad compliance and developed grade IV OM. Conclusions: Use of a validated scale for reliable assessment is the fi rst step in a comprehensive program to reduce a highly distressing side effect after HDCT with ASCT. Supersatured calcium and phosphate mouthwash solution had a good tolerance. A randomized study should be conducted to evaluate the effi ciency.
P1304
Addressing oncology nursing issues by bridging language barriers
A. Atanante King Faisal Sp Hosp & Research Centre (Riyadh, SA)
With over 180 million populations from 22 countries in the Middle East and North Africa, the Arab World speaks a common Arabic language, and share similar, if not the same values and beliefs of the Arab culture. To understand Muslims, a basic knowledge of Islam is essential. Saudi Arabia claims host to King Faisal Specialist Hospital & Research Center (KFSH&RC), so far the largest tertiary healthcare and research facility in the country and the Gulf Area, is a melting pot of some twenty nationalities comprising its workforce, including nurses. One of the barriers to effective nursing care at KFSH&RC in general and the Adult BMT Unit in particular is that patients speak no English and caregivers speak little or no Arabic at all. It is not uncommon that patients and families may be as frustrated as the nurses because they can't understand each other. Beyond basic bedside care and medication administration, a lot of patient and family education is required before, during and after transplantation, not to mention preparations for discharge and rehabilitation. Once dominated by Westerns and Europeans supported by interpreters, the hospital's nursing workforce is now a blend of Asians and Middle Easterns with only about 4% Saudis. This presentation will highlight how nurses were challenged to collectively address the communication barrier and how their overall experience, recommendations and success demonstrated by better patient outcomes infl uenced the continuing education and support of their nurse colleagues at the hospital-wide level and nearby facilities as well.
P1305 Aspects of adaptation process in haemato-oncology M. Zitkova (1), P. Jurenikova (2), J. Spackova (1), P. Rezacova (1) (1)University Hospital Brno (Brno, CZ); (2)Faculty of Medicine (Brno, CZ)
Background: The adaptation process represents a key period in the professional life of all nurses, principally infl uencing, whether or not they will continue working in their specialty, and launching their further professional and personal development. The education of new staff ranks among the priorities of nursing managers. Methods: A questionnaire survey was performed between 2008 and 2010. The target group of respondents included freshly graduated general nurses starting to work at the Internal Hemato-Oncology Department. The questionnaires were distributed in intervals 3 months (Group A) and 12 months (Group B) after the nurses started to work. The total group involved 60 respondents. This total number was limited by the number of staff beginning to work at the department. Results: Group A: As far as the length of work with the support of a supervisor is concerned, 58 % respondents gave 4 weeks, 16% gave 5 weeks and 3 weeks and only 10% gave 2 weeks. All 100% of respondents stated that they had been satisfi ed with the service. As far as the greatest help offered in this period is concerned, 87% respondents mentioned the support provided by the supervisor and colleagues, 10% appreciated frequent repletion of interventions and 3% respondents found help in their strong will. The beginning of independent work was characterized by nervousness 35%, fear and worries 26%, and insuffi cient organization of work 16%. The most feared activities at the beginning of independent work were represented by the organization of work and performing the orders 17%, handling chemotherapy 12%, handling venous catheters and blood collection 10%. Further feared activities included care of the dead and resuscitation 7%. In Group B: As persisting feared activities -resuscitation 31%, care of the dead 18%, lack of activities 14% and new activities 11%, are mentioned. The cooperation with the supervisor was evaluated with the mark 1 by 86% of the respondents. Conclusions: In order to manage the adaptation to work properly, it is necessary to have the highest possible amount of information on the needs, problems, particular activities which the beginning nurses face in everyday practice. In August, 2009, the Czech Ministry of Health issued Methodological Instructions for the management of the adaptation process, which provides the framework of how to manage this long-term and systematic care of the beginning staff successfully.
P1306
To maintain retention on a high acuity paediatric haematopoietic stem cell transplant unit
S. Tang, D. Landery, M. Moses Children's Hospital Los Angeles (Los Angeles, US)
Working on a high acuity Hematopoietic Stem Cell Transplant (HSCT) unit can be physically, mentally and emotionally demanding. To maintain nurses on this high stressed unit can be challenging. Previous data has shown that oncology nurses have been identifi ed as a group at risk for stress (Campos de Carvalho, 2005) . Stressful factors may include: personal confl icts with other staff members, job dissatisfaction, staffi ng shortage and work place burnout cause by the constant loss of patients which is common in a stem cell transplant setting. At Children's Hospital Los Angeles we work with a multitude of multidisciplinary teams to maintain the consistency of our staff. A variety of services are offered to our staff through the hospital. Spiritual care services provide emotional support during stressful times when the staff is dealing with loss of a patient. An employee assistance program provides free confi dential mental and emotional support to staff either on a personal or professional level. This program also provides a variety of activities through out the year to help reduce burnout in the hospital setting such as a Health Wellness Fair for employees. On our pediatric HSCT unit we have implemented a Retention and Recruitment committee to help retain our nurses. The committee members gather on a quarterly basis to discuss the morale on the unit and to plan for future unit based activities. The goal of our committee is to offer our staff a work setting that is supportive on a professional and personal level. We found that being supportive in the personal lives of our colleagues is just as important as supporting them professionally. This poster will highlight resources used to help decrease stress and maintain a healthy work environment for the staff on a high acuity pediatric HSCT unit.
P1307
Results of a survey on the staff knowledge about malnutrition in haematology units in Saint Antoine hospital in Paris (CHU, AP-HP), France V. Laube, S. Nadji, E. Tousaint Hopital Saint Antoine (Paris, FR) Introduction: Moderate malnutrition is frequent in European hospitals. Malnutrition prior to transplants has been reported as being a negative prognostic factor for survival following haematopoietic stem cell transplantation. The National Nutrition and Health Programme (PNNS) and the institutional project recommend screening for malnutrition. The nutritional support team conducted a survey to evaluate staff knowledge about malnutrition. The aim of this project was to encourage interaction between the staff and the nutritional support team so that they could become better acquainted, and to enhance staff awareness of patient malnutrition. This poster summarizes the fi ndings of the two haematopoietic stem cell transplantation units of our hospital. Methods: Questionnaires were distributed to doctors, nurses, auxiliary nurses, students and secretary in June 2011. The intent of this process was educational. Oral and written answers were returned to participants with a guide on malnutrition. 43 persons accepted to take part in. Nurse, auxiliary nurse and doctor participation represent respectively 58%, 21% and 7% of the answers. Results: 30% quoted all of the criteria of malnutrition screening. The aspect the most frequently mentioned was the body mass index (95%). Although 70% were aware of how to calculate it, only 42% knew the exact standards. 84% quoted biological data, and 65% weight variations. 44% correctly estimated risk situations, 58% the consequences (the increased duration of hospitalisation and risk of infections), and the percentage of malnutrition at the hospital. Allowing patients to choose their meals was not noted as one of the fi rst actions that should be adopted in the treatment of malnourished patients. This being said, giving sip feeds (93%), recording food consumption (86%) and enteral feeding (65%) were mentioned more often than in other units. People have limited knowledge of the quality nutritional criteria required for hospital accreditation. 28% know the nutritional team tasks, and less than 10%, the nutritional tools available on the website. Haematology unit answers varied little from the mean of the hospital units answers. Conclusion: This survey shows that staff knowledge about screening malnutrition is still inadequate. The benefi t of collaboration with dieticians, however, is perceptible in improved patient care in haematology units. Nutritional support team must continue its efforts to communicate about nutrition: training, tools, website. Aim: The nurses' standards include training program, formally experience in the management of adult and paediatric patients receiving hematopoietic stem cells (HSC) and maintenance of competences during the time. The main aim was to highlight common and different points between the tools. Moreover, to promote integration, experience exchange and development of TP quality and safety. Method: The TP structured the practice activities and brought in the changes for adapting to JACIE standard. The nurses planned the working educational phases, the accurate timing of evaluation and results publication. They revised the job description, the new recruit educational program and the retraining annual plan. Subsequently, 2 tools for the continuous evaluation of nurse competences were performed according to the paediatric and adults HSC topics. Results: The 2 tools represent a shared and reproducible system and contained measurable markers for new recruit and expert nurses. The HSR tool, unlike the other, has both the quantitative and qualitative evaluations. The tools' strong points are the traceability, the promotion of multi-discipline team development and the adaptation to contest. The limits are the arbitrary definition of targets, depending on the mean HSC activity, and the subjective aspects of qualitative evaluation. Conclusion: The nurses lived the accreditation path as challenge for the quality improvement of patient care and were aware of the big involvement and the own limits. The process represented an helpful instrument for identifying roles and responsibilities. The comparison allows us to point out critical points in order to fi nd the solutions. In the future, it is desirable to create a national specifi c educational program to recognize an institutional role for nurses dedicated to the improvement of quality system.
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Strategies to support newly qualifi ed nurses on a stem cell transplant unit E. Eves, C. Kay Royal Marsden Hospital (Sutton, UK) Newly qualifi ed nurses are a unique group of staff who have very specifi c learning needs. Historically the transplant unit at the Royal Marsden has not recruited newly qualifi ed nurses as it was unable to provide them with suffi cient academic and practical support. To adhere to the required Jacie standards for the training of nurses and to enable newly qualifi ed nurses to be recruited onto the transplant unit, a new learning programme, addressing both their academic and practical needs, was developed. Upon joining the Trust these nurses are supplied with a staff handbook, and receive an orientation day carried out by a senior nurse.
All new nurses are allocated a dedicated mentor for individualised support throughout a 4 week supernumery period. During this period their specifi c mentor will work at least 90% of the time with them, the other 10% covered by another qualifi ed mentor. On completion of this period, new nurses are given a 'buddy' for each shift to ensure that they have a defi ned source of support. To address their academic needs all newly qualifi ed nurses are offered a dedicated 12 month training programme consisting of study days and a route learning map covering subjects such as nutrition, symptom management and oncological emergencies. The unit has also developed a specifi c haemato-oncology route learning map which enables them, with the support of their mentor, to take responsibility for gaining knowledge of an aspect of transplantation such as high dose chemotherapy, types of transplants and GVHD. To enable them to gain further specialized knowledge they attend 3 haemato-oncology compulsory study days per year with other staff from the unit. The unit has a clinical educator who dedicates at least 70% of her time working clinically. She works closely with the newly qualifi ed nurses using a set of newly developed learning plans to stage their learning thereby preventing 'information overload'. Throughout the learning period the clinical educator meets regularly with the mentor and the learner to offer support and guidance. We aim to continue this programme and act on any feedback we receive, whether positive or negative to enable us to provide the optimum support to the newly qualifi ed nurses working on the transplant unit.
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Bone marrow harvesting as an extended role for the BMT nurse: a pilot experience in Oman and recommendations for the EBMT nursing group R. Al Mahrizi, C. Lagar, J. Goes, S Wilson, A. Juanitas, E. Gallardo, J. Thomas, B. Mathew, Y. Al Habsi, Z. Al Harthi, S. Simon, C. Trampe, C. Biniza, J. Jobi, D. Mathew, M. Mathew, R. Kunjan, I. Al Manthari, V. Recto, R. Varghese, K. Al Salmi, S. Jose, N. Al Siyabi, S. George, J. John, M. Al Khabouri, K. Al Farsi, M. Al Huneini, A. Al Rawas, S. Al Kindi, D. Dennison Sultan Qaboos University Hospital (Muscat, OM) The role of the BMT nurse is continuously expanding from exclusive nursing care of the BMT patient to include management roles outside the BMT unit. Such diversity provides the opportunity to the trained BMT nurse to learn and utilize specialized skills within the background of BMT nursing. Out of need and in an effort to make BMT nursing more appealing, the BMT program at the Sultan Qaboos University hospital in Oman decided to permit nurses to harvest bone marrow under the supervision of the transplant physician. The idea was for them to learn a new skill so as to be able to assist in this procedure. Between February 2005 till date, three of our nurses have continuously been involved with bone marrow harvesting in this institution. They have been taught the procedure by the responsible transplant physician and have acquired the required skills. A checklist (Figure 1 ) based on ten components of the entire harvest procedure was developed. For each procedure the checklist was verifi ed by the nurse, signed by the transplant physician and kept in her portfolio as documentation of competency. Currently in our center the BMT nurse assists the transplant physician in all harvest procedures in the operating room (OR) such that it has become an integral part of our transplant program. We recommend bone marrow harvesting as an extended role for the BMT nurse as it minimizes the need for an extra physician in the OR while at the same time providing an opportunity to diversify from traditional nursing patient care. On a broader perspective, bone marrow harvesting should be included in the nursing curriculum provided institutional legal cover is secured.
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Central venous pressure measurement -development of a video N. Domingues, M. Tomeo, N. Borràs, A. Mantecon, M. Valverde Hospital Clinic (Barcelona, ES) Background: Since March 2008 in our Institution the Joint Accreditation Committee -ISCT and EBMT (JACIE) accreditation offi cially states that the Stem Cell Transplantation (SCT) Programme fulfi ls JACIE requirements; JACIE Standards accomplishment guarantees quality services to patients undergoing Autologous or Allogenic SCT. Standards of care are planned by the Clinical Quality Committee. In 2011 it was proposed to create a Standard Operating Procedure (SOP) for Central Venous Pressure Monitoring (CVP). Once created the SOP it was implemented. Aim: To produce a video as a support tool to facilitate implementation and adherence to the SOP. Method: The idea to create a video about CVP monitoring brought up when low enthusiasm about a new SOP was stated; even though assessment of systemic fl uid status is an important procedure in hematologic patients undergoing SCT. In September 2011 the recording was done, all the clips analysed and carefully selected. Results: This is the fi rst SOP supported by a video, designed for both new and experienced nurses working at the SCT unit who can view it because is available at the hospital's intranet to take full benefi t of it. Conclusion: From our understanding providing encouragement, support and introducing new technologies in continuous education and clinical training will help to motivate and promote adherence. Next proposal is to explore effectiveness of the video.
[P1310] P1312 How to educate nurses for using implantable venous access system port-a-cath -our experience K. Jugar, N. Luppova, O. Zolotova, G. Kõks, A. Kaare, H. Everaus Tartu University Hospital (Tartu, EE) Objectives: Ten years ago we used port-a-cath systems only for child patient with cancer. In last couple years we have trying to use port-a-cath increasingly for adult patient who have suffered for hematological or oncological diseases. Implantable venous access systems are permit to repeated access for short or long-term infusions of medications, blood products, nutritional and other fl uids, such as bolus injections, and venous blood sampling. Connection for increased using port-a-cath systems we have much more central venous catheters infections. On the basis of literature 15% for patients with port-a-cath had faced some of the complications. It´s mean that role of nurses skills, how to use port-a-cath system, are very important. Methods: We have composed guideline for nurses how to use implantable venous access system Port-a-cath, how to insert/ remove Huber needle and what kind of complications could appears. After that we have organized several practical study days for nurses and they all has to test how to insert/remove Humber needle and how to handling safely port-a-cath. For practical study we have a little piece of pork. Results: We hope that now, after many study days, we have less central venous catheter infections and others complications but we don´t have any statistical results or proof. We can say that very certainly our nurses skills and knowledge are much better and we had standardized port-a-cath using skills. For the present almost 100 oncology nurses had educated in Tartu University Hospital by our team. Conclusion: Specially trained nurses had skills how to use porta-cath system, how to avoid complications and how to educate patient with port-a-cath. Introduction: Bone marrow-derived mesechymal stem cells (MSC) are increasingly being used in the allo-HSCT setting for a number of transplant complications, including graft failure, graft-versus-host disease (GvHD) or peripheral cytopenias. The correct application of the administration procedure is a key issue to obtain a successful outcome, since MSC display different properties compared to hematopoietic stem cells, that include their characteristic plastic adherence and their larger volume. Objectives: To analyze the safey of MSC administration in our Institution by monitoring adverse during and after cell infusion, and to validate the MSC infusion protocol followed by the nursing staff. Methods: We have prospectively recorded the adverse events occurred during or after MSC administration in 30 patients (with a total number of 125 cell infusions) from our institution consecutively treated, following a infusion protocol designed by the good manufacturing practices-facility staff (GMP-facility staff). Results: No serious adverse events during or after the administration process were recorded after 125 procedures, thus validating our MSC infusion protocol for the nursing staff. Conclusion: With the experience accumulated after 125 procedures of MCS administration, our study shows that the procedure is safe and do not involve serious risk for allo-HSCT (allo-hematopoietic stem cells transplant) recipients if the infusion protocol is thoroughly followed.
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The role of BMT nurses in mobilisation and collection of peripheral blood stem cells for autologous transplantation in children with cancer -single-centre experience A. Aleksova, I. Angelova, T. Buncheva, H. Nikolova, V. Brankova, C. Bakalska Specialized Hospital for POH (Sofi a, BG) High-dose chemotherapy followed by autologous hemopoietic stem cell (HSC) support is a salvage treatment option for children with relapsed or refractory malignant diseases. Peripheral blood stem cells mobilized from bone marrow represent the most used source of hemopoietic cells. Collection of the cells is realized through apheresis. This process is performed by a multidisciplinary team, including specially trained nurses. In our hospital the same training nurses participate in cell collection process and later in transplantations and their activity is very specifi cally because they attend to children. We present the nurse's role in mobilization and collection of HSC in SHPOH in Sofi a. From October 1997 to October 2011 in our Hospital were realized 140 mobilizations and 232 collections in 121 children with neoplastic diseases (lymphoma, leukemia and solid tumors). The mobilizations were carried out with combination of chemotherapy and G-CSF or only with G-CSG, and the role of nurses included cares for patients during chemotherapy regimens and applications of G-CSF daily. All collections were carried out trough central venous catheter (CVC) on the day after mobilization with Leuc≥2500/mm 3 , Hb≥100 g/dl, Thr≥50000/mm 3 and CD34+ cells ≥10/mcl, using cell separator Fresenius COM. TEC and apheresis programs according to the patients age and CD34+ cells number. The nurse's competency in collection process included care for CVC, technical support in preparation of cell separator for apheresis session and observation and care for children during collection process. In all patients were collected suffi cient number of HSC for autologous transplantation with 1-3 aphereses (CD34+ cells ≥2x10 6 /kg body weight). We did not observe any serious side effects of mobilization and collection. All patients were transplanted in different time after collection in accordance to the disease protocols. Mobilization and collection of peripheral blood stem cells are very important part of HSC transplantation, from which extremely dependent the result of this treatment. The role of nurses is of primary signifi cance for the successful cell collection and the good condition of the children during this treatment period.
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From the insertion nurse to the PICC team: an Italian experience C. Soliman, P. Brambilla, V. Matozzo, I. Battini, F. Ciceri, A. Assanelli, C. Corti San Raffaele Hospital (Milan, IT) Background: In February 2008, the Peripherally Inserted Central Catheter (PICC) project started in the Haematology and Bone Marrow Transplantation Unit in answer to clinical-organizational needs, thanks to the wishes of making a change in the patients care interest and of improving the nurse expertise in a multidisciplinary health setting. The project was shared with the medical-nurse representatives and supported by the haematologists. The professionals agreement due to the PICC advantages made possible the development of a competent team dedicated to the PICC insertion and management. Aim: The aims were to rationalize the use of central venous catheter (CVC) and to have a safe medium-long term CVC for patients with thrombocytopenia, diffi cult venous accesses and lengthy infusion therapy. Moreover, to assure the best quality of life to the patients during the hospitalization and at home, by reducing punctures and main vascular access complications.
Finally, to establish a competent and organized hospital service able to satisfy the adult and paediatric patients needs. Method: 2 Haematological nurses attended the insertion PICC training course and were tutored from a clinical sales specialist. 2 Haematologists were identifi ed to take clinical decisions after doing assessment with the insertion nurses. The informed consent and the inclusion and exclusion standards form were introduced. The nurses educated patients and gave satisfaction questionnaires up. PICC were inserted at the Haematology Day Hospital where an ultrasound scanner was available. Recently, another nurse attended the PICC insertion course. Results: From 2008 to 2011, the performed PICC insertions were 384: 11 Out of 384 were inserted in paediatric patients and 373 in adults from several Departments: Haematology, Oncology, Rehabilitation, Medicine, Surgery and Emergency. Four theoretical courses for physicians and nurses and many practical meetings between nurses were performed. The insertion nurses and the haematologists worked in a collaborative setting. Conclusion: The project success required constant involvement, despite the limited number of qualifi ed nurse that caused delays and temporary stops of service. The lack of PICC knowledge made some professionals distrustful and use-resistant. The patients positive feedback enhanced the medical-nurse motivation to improve the project. The experience taught us that the PICC use required dedicated and trained team composed by competent professionals. Introduction: This study evaluated haematology patients' satisfaction with their review undertaken by the ANP in haematology. The study also evaluated patients' satisfaction with bone marrow (BM) examinations performed by the ANP. The study team included the ANP in haematology and three nurse lecturers based at an Irish university. Patient satisfaction is a signifi cant factor in contribution to the patient's well being. Evaluating patient satisfaction is therefore central to evaluating health care service provision. In Ireland, the evaluation of the ANP role is in its infancy. There is some evidence of this new role's positive impact in surveys undertaken by a number of ANPs in recent years. However, this is the fi rst known study with Irish haematology patients. Methodology: The study questionnaire was developed from an adaptation of two pre-existing published questionnaires developed in the US. The questions asked focused on patient care, patients' views on the ANP's knowledge of their diagnosis, the ANP's courtesy and respect, and satisfaction with how bone marrow examination was performed. Following ethical approval, a database of all eligible patients was compiled. This included all patients reviewed by the ANP between June 2010 and 2011, and all patients who had a BM examination performed by the ANP during this time. 405 patients and 111 bone marrows were completed by the ANP during the study timeframe. Based on calculations derived from the raosoft sample size calculator, a sample size of 200 reviews and 87 bone marrows was required. Patients were randomly selected (every second patient) from the ANP patient database using the medical record no (MRN). 300 patients received a letter inviting them to complete the questionnaire and return their completed questionnaire to one of nurse lecturers on the study team.
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Findings/Conclusion: A total of 147 questionnaires were returned. The data is currently being analysed using SPSS, and descriptive statistically results on the returned questionnaires will be presented. Patients' qualitative responses to the open question on the questionnaire will also be presented.
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Implementation of "primary nursing" assistance model in haematoncology department: from theory to practice (results after six-month observation) T.S. Suardi, L.O. Orlando, A.b. Babic, S. Bertelli, G.M. Martinelli, G.M. Magon European Institute of Oncology (Milan, IT) Background: Haematoncological patients are delicate patients who requires particular care and nurses involved in their assistance needs to guarantee their complex care. In our Institute we implement "Primary Nursing" assistance model, with objectives to guarantee continuous assistance to patients. Objectives: To guarantee "Continuous Assistance" by its:
• Table; • Elaboration of dedicated patient's Brochure; • Direct consignment between nurses on shift changes.
Since April18, 2011 we implement this model with new documentation and elaboration of nurse's work planning. Further we elaborated the Questionnaire for physicians, nurses and patients involved with objectives to evaluate the adherence to new assistance model. This questionnaire were distributed 6 months after implementation, and will be distributed after 12 and 18 months. Conclusions: The fi rst evaluation has been observed six months after the implementation with results that "Primary Nurse" assistance model seems to facilitate reaching of higher level of nurse assistance determining conditions and autonomy to each professionals. Patients appreciate this model and states to feel "much secure" having their reference nurse, They feel to be "in the center" of continuous care. Continuity of assistance from patient's admission to dismissal, fl ow of information and coordination between different professionals involved is guarantee by assistance planning of the reference nurse. Partial (six months) results in Table 1 .
P1318 The patient's experience of neutropenic sepsis S. Wigfall The Royal Marsden NHS Foundation Trust (Sutton, UK)
Neutropenic sepsis is a major complication of treatment for haematological malignancies, 70% of patients will experience an infection during treatment resulting in a considerable risk of neutropenic sepsis for this patient population (Hamalainen, 2009) . The literature review suggested that surviving a critical illness such as sepsis is similar to that of posttraumatic stress disorder survivors (McGrath, 1999) and cancer survivorship (Doyle 2008). The presented research will be an examination of the patient's experience of neutropenic sepsis for haematological malignancies. A qualitative phenomenological methodology was used for the research using semi-structured interviews. Ethical approval was gained from the South West London ethics committee. Giorgi's (1997) method was used for the data analysis. The results of the study are presented using a theoretical framework based on the cancer survivorship literature, with the meaning of the experience displayed using the titles of physical, psychological, social and spiritual health. The meaning units subdivide the data into the onset and the subsequent experience of neutropenic sepsis. 14 meaning units emerged, the onset being described as rapid, with rigors and feeling an unbelievable coldness. The psychological aspects included, survival and fear, depression and mental strength, loss of control, waiting for counts to return, dreams and hallucinations. Physical diffi culties included practical aspects and fatigue. Social and spiritual health involved the value of families and trust of specialist hospital and long term consequences of the experience.
[P1317]
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Conclusions will be presented from the research to display these meaning units related to the experience of neutropenic sepsis for patients. Weaknesses and limitations of the research will be fully displayed. This study has been undertaken as part of an MSc nurse practitioner in cancer care programme.
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Service evaluation -long-term follow-up in a stem cell transplant clinic S Davis, J.a Brennan Royal Marsden Hospital (Surrey, UK) Haemopoetic Stem cell Transplantation (HSCT) is an effective and curative treatment for various malignant and non-malignant diseases. With technological advances in histocompatability testing, supportive care, and conditioning regimens the annual number of HSCTs is increasing with an expansion of diseases being considered appropriate for HSCT. Consequently increasing number of patients are surviving the acute episodes and become long term survivors. Not all however enjoy good health and experience physiological effects that include organ dysfunction, infections related to delayed immune reconstitution, secondary cancers, graft versus host disease and quality of life issues. Some of these "late" effects occur as early as 3 months post HSCT whereas others can manifest months or years later. A close partnership between transplant centre and organ specifi c specialities is a key component of preventative medicine and improving long term outcome. In 2004 our centre started a clinic specifi cally for this growing group of patients, to assess, monitor and systemically screen for any abnormalities expediting referrals to other health experts. In November at EBMT Nurses Group & the EBMT Swiss Nurses Working Group we presented the rationale for the clinic and our experiences. 200 surviving patients' experiences have been analyzed for a service evaluation which we would like to present at EBMT Geneva Nurses group. The aim of the service evaluation is to establish outcome for these patients following Allogeneic HSCT with regards to secondary cancers, and other long term effects of treatment. Background: Allogeneic Haematopoetic Stem Cell Transplant (HSCT) is a potentially curative treatment for haematological cancers. However, it is a particularly aggressive treatment that can impact individuals' quality of life (QoL) in multiple ways. Due to the toxicity of the transplant, adults aged over fi fty years have only recently become eligible for this treatment, following the development of a reduced intensity regimen. As a result, little is known regarding the experience of QoL among recipients aged over fi fty years. QoL information is an essential part of assessing the success of medical treatments and can help prepare recipients for the ways in which their lives and those of their families may be impacted post-transplant. Method: Potential participants were recruited through the Beatson West of Scotland Cancer Centre in Glasgow, UK and a purposive sample of eight participants volunteered to take part in the study. A qualitative approach, Interpretative Phenomenological Analysis (IPA), was used to explore the experience of QoL in these patients.
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Results: Four superordinate themes emerged from the data; 'Shifting Sense of Self and Others', 'Adaptation and Managing the Impact', 'A New Perspective on Life and Living' and 'Changing Over Time'. The fi ndings helped highlight the challenges and gains experienced by HSCT recipients as well as the process of adaptation and adjustment which mediates the impact of HSCT on QoL. Conclusions: The participants in this study demonstrated that there are a number of commonalities between younger and older recipients in terms of post transplant QoL when compared to the literature on younger recipients to date. However, increased age and stage of life was also shown to have a unique impact of the subjective experience of QoL after transplant. Increased age continues to represent a signifi cant risk factor in terms of QoL and survival post transplant. However, the fi ndings from this study suggest that this small sample of recipients is adjusting well to the challenges of HSCT. Further research is required in this area.
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Quality of life after haematopoietic stem cell tranplantation in adults M. Quaghebeur, F. Vandenbussche, J. Vincke, L. Noens University Hospital Ghent (Ghent, BE) Objective: Despite a growing number, hematopoietic stem cell transplantation remains a drastic treatment requiring high level of care. Decreased quality of life and impaired functional status are often associated problems after a transplantation. Our study aimed to gain more insight in quality of life, as well as its infl uencing factors, after hematopoietic stem cell transplantation. The results can support the establishment of a care pathway with improved patient follow-up. Method: In the follow-up after both autologous and allogeneic transplantation, adult patients were asked to complete two validated quality of life questionnaires, i.e the EORTC QLQ-C30 version 3 and the City of Hope quality of life questionnaire. We included patients of 18 years or older, Dutch speaking, who received transplantation between 2005 and 2011. The questionnaire was applied at least 60 days after the intervention. Patients in palliative care or in treatment for relapse or for other non hematological diseases were excluded. Data were analyzed using two-way Anova. Results: From January to April 2011, 106 post hematopoietic stem cell transplantation patients visited the policlinic for a follow-up consultation. Of these, 14 did not meet the inclusion criteria. Out of the 92 patients who received the questionnaire, 76 completed it (response rate of 86%): 50 patients underwent an autologous stem cell transplantation, 13 patients a full allogeneic stem cell transplantation, and another 13 a mini-allogeneic stem cell transplantation. Our results showed signifi cant differences in physical and cognitive functioning, experiencing of fatigue, occurrence of diarrhea and occurrence of pain according to the different periods after stem cell transplantation and to the type of transplant. The presence of graft-versus-host disease, having received total body irradiation and the level of the patient's professional activities clearly affected the overall quality of life. Conclusion: The establishment of a care pathway including systematic monitoring of quality of life characteristics in posttransplant patients will allow the nurse consultant to address appropriate recommendations in a timely and personalized manner. Issues requiring particular attention from the hematologist can be identifi ed in advance of the consultation. It is anticipated that this will lead to an overall improved management of post-transplant patients.
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Transdisciplinary project: enhancement of physical activity for long-term hospitalised onco-haematological children V. Bernhard, M. Bouchardy, G. Cristiano, H. Ozsahin, F. GumyPause, M. Ansari HUG (Geneve, CH) Introduction: The onco-hematological unit of the Children's Hospital in Geneva treats children from 0 to 16 years. They are often hospitalized for months, sometimes with long periods of seclusion due to infections secondary to decreased immunity. Issues: Before the projects implementation, physical activity was not a priority. Patients moved without specifi c guidance. If physical therapists was involved, it was with a curative aim for specifi c respiratory, loco-motor or neurological issues. Preventive support regarding physical activity was not planned. Scientifi c studies have however shown the importance of maintaining regular physical activity during long-term hospitalization. Aim: Set up a project integrating playful, structured and individually adapted physical activity in the patient's care. Method: Constitution of a trans-disciplinary working group (nurse, physical therapist, adapted physical education teacher) whose role was to defi ne the project's priorities, choose the required equipment, raise funds and encourage the caregiver's involvement in this change of paradigm. Project implementation: Data gathering concerning the child's usual physical activity in order to establish an individually fi tted program. Implementation of daily physical therapy. Provide fi tness bikes. Installation of Wii video game consoles. Demonstration and instruction in the use of the game console aiming to handle independence for the patient and his family. Use of music to support activity. Discussion with the family about the importance of physical activity in the short and long term. Results: Physical activity is now included in the care of long-term hospitalized patients with awareness of its importance. Physical activity is enjoyed. This feeling is shared by patients, families and caregivers. Patients have gained independence in continuing physical activity even if no caregiver is attending him. Too much muscle loss is avoided but bone mineral density still has to be periodically performed. Conclusion: Results are positive for the patients but various organizational problems occurred: managing and adapting the equipment, especially for small children, was not always easy. As caretakers don't have time to spend on these tasks, an additional person is needed to support the team in this job.
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Donor lymphocyte infusions in patients with haematological malignancies being treated with an allogeneic stem cell transplantation. A single centre experience A. Jansen, J. Hall, J. Craig, C. Crawley, A. Sureda Addenbrookes Hospital (Cambridge, UK) Objectives: Analyze the population characteristics, side effects and outcome of 45 patients with haematological malignancies being treated with an allogeneic stem cell transplantation (allo-SCT) and receiving donor lymphocyte infusions (DLI) after transplantation in our centre. Patients and Methods: From February 1997 to November 2010, 45 patients (26 males/19 females) (13 AL, 10 CML, 10 MDS, 5 lymphomas, 4 CLL and 1 MPN) with a median age (range) of 44 (17-63) years at the time of allo-SCT were treated with DLI after transplantation. In 21 patients, the donor was a HLA identical sibling, in 20 a matched unrelated donor and in 4, a mismatched unrelated donor. Peripheral blood was used as the source of stem cells in 29 patients. Thirty four patients received a reduced intensity conditioning allo-SCT and the remaining 11, a myeloablative conditioning. All CML patients were allografted in chronic phase. 10 of the non-CML patients (n = 35) were allografted in complete remission, 16 patients in partial remission and the remaining 9 in resistant disease. Results: Characteristics and development of graft-versus-host disease (GVHD) after the DLI are depicted in the following Table. At the time of this analysis, 26 patients are alive (15 in complete remission and 11 with active disease) and 19 patients died, 15 of them because of progression of the underlying disease, 2 because of DLI associated problems (1 aGVHD and respiratory infection and 1 because of an infectious episode), 1 because of a car accident and the remaining patient from an unknown cause. One of the patients dying because of DLIassociated toxicity was in complete remission of his underlying disease. Conclusions. In our centre, DLI were equally used to treat both mixed chimerism and disease relapse / progression after allo-SCT. The use of DLI is a potent treatment to reverse mixed chimerism to full donor chimerism, and to achieve complete remission. DLI will have an impact on quality of life if aGVHD occurs. It is crucial that the patient understands the symptoms of aGVHD and infection to reduce the risk of delaying treatment for aGVHD. The development of GVHD after DLI decreases with the number of DLI administered and it represents the major toxicity of this treatment.
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